0001306830-21-000203 10-Q 107 20210930 20211022 20211022 Celanese Corp 0001306830 2820 980420726 DE 1231 10-Q 34 001-32410 211340665 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 972-443-4000 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 Celanese CORP 20041102 Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. 20041022 10-Q 1 ce-20210930.htm 10-Q 000130683012/312021Q3false31100013068302021-01-012021-09-300001306830us-gaap:CommonStockMember2021-01-012021-09-300001306830ce:SeniorUnsecuredNotesDue2023Member2021-01-012021-09-300001306830ce:SeniorUnsecuredNotesDue2025Member2021-01-012021-09-300001306830ce:SeniorUnsecuredNotesDue2027Member2021-01-012021-09-300001306830ce:SeniorUnsecuredNotesDue2028Member2021-01-012021-09-30xbrli:shares00013068302021-10-15iso4217:USD00013068302021-07-012021-09-3000013068302020-07-012020-09-3000013068302020-01-012020-09-30iso4217:USDxbrli:shares00013068302021-09-3000013068302020-12-310001306830us-gaap:CommonStockMember2021-06-300001306830us-gaap:CommonStockMember2020-06-300001306830us-gaap:CommonStockMember2021-07-012021-09-300001306830us-gaap:CommonStockMember2020-07-012020-09-300001306830us-gaap:CommonStockMember2021-09-300001306830us-gaap:CommonStockMember2020-09-300001306830us-gaap:TreasuryStockMember2021-06-300001306830us-gaap:TreasuryStockMember2020-06-300001306830us-gaap:TreasuryStockMember2021-07-012021-09-300001306830us-gaap:TreasuryStockMember2020-07-012020-09-300001306830us-gaap:TreasuryStockMember2021-09-300001306830us-gaap:TreasuryStockMember2020-09-300001306830us-gaap:AdditionalPaidInCapitalMember2021-06-300001306830us-gaap:AdditionalPaidInCapitalMember2020-06-300001306830us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001306830us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001306830us-gaap:AdditionalPaidInCapitalMember2021-09-300001306830us-gaap:AdditionalPaidInCapitalMember2020-09-300001306830us-gaap:RetainedEarningsMember2021-06-300001306830us-gaap:RetainedEarningsMember2020-06-300001306830us-gaap:RetainedEarningsMember2021-07-012021-09-300001306830us-gaap:RetainedEarningsMember2020-07-012020-09-300001306830us-gaap:RetainedEarningsMember2021-09-300001306830us-gaap:RetainedEarningsMember2020-09-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-3000013068302020-09-300001306830us-gaap:NoncontrollingInterestMember2021-06-300001306830us-gaap:NoncontrollingInterestMember2020-06-300001306830us-gaap:NoncontrollingInterestMember2021-07-012021-09-300001306830us-gaap:NoncontrollingInterestMember2020-07-012020-09-300001306830us-gaap:NoncontrollingInterestMember2021-09-300001306830us-gaap:NoncontrollingInterestMember2020-09-300001306830us-gaap:CommonStockMember2020-12-310001306830us-gaap:CommonStockMember2019-12-310001306830us-gaap:CommonStockMember2021-01-012021-09-300001306830us-gaap:CommonStockMember2020-01-012020-09-300001306830us-gaap:TreasuryStockMember2020-12-310001306830us-gaap:TreasuryStockMember2019-12-310001306830us-gaap:TreasuryStockMember2021-01-012021-09-300001306830us-gaap:TreasuryStockMember2020-01-012020-09-300001306830us-gaap:AdditionalPaidInCapitalMember2020-12-310001306830us-gaap:AdditionalPaidInCapitalMember2019-12-310001306830us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300001306830us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300001306830us-gaap:RetainedEarningsMember2020-12-310001306830us-gaap:RetainedEarningsMember2019-12-310001306830us-gaap:RetainedEarningsMember2021-01-012021-09-300001306830us-gaap:RetainedEarningsMember2020-01-012020-09-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300001306830us-gaap:NoncontrollingInterestMember2020-12-310001306830us-gaap:NoncontrollingInterestMember2019-12-310001306830us-gaap:NoncontrollingInterestMember2021-01-012021-09-300001306830us-gaap:NoncontrollingInterestMember2020-01-012020-09-3000013068302019-12-310001306830srt:EuropeMemberce:EngineeredMaterialsMember2021-01-012021-09-300001306830srt:EuropeMemberce:EngineeredMaterialsMember2021-09-300001306830ce:EngineeredMaterialsMember2020-12-310001306830ce:AcetateTowMember2020-12-310001306830ce:AcetylChainMember2020-12-310001306830ce:EngineeredMaterialsMember2021-01-012021-09-300001306830ce:AcetateTowMember2021-01-012021-09-300001306830ce:AcetylChainMember2021-01-012021-09-300001306830ce:EngineeredMaterialsMember2021-09-300001306830ce:AcetateTowMember2021-09-300001306830ce:AcetylChainMember2021-09-300001306830us-gaap:LicensingAgreementsMember2020-12-310001306830us-gaap:CustomerRelationshipsMember2020-12-310001306830us-gaap:DevelopedTechnologyRightsMember2020-12-310001306830us-gaap:OtherIntangibleAssetsMember2020-12-310001306830us-gaap:LicensingAgreementsMember2021-01-012021-09-300001306830us-gaap:CustomerRelationshipsMember2021-01-012021-09-300001306830us-gaap:DevelopedTechnologyRightsMember2021-01-012021-09-300001306830us-gaap:OtherIntangibleAssetsMember2021-01-012021-09-300001306830us-gaap:LicensingAgreementsMember2021-09-300001306830us-gaap:CustomerRelationshipsMember2021-09-300001306830us-gaap:DevelopedTechnologyRightsMember2021-09-300001306830us-gaap:OtherIntangibleAssetsMember2021-09-300001306830us-gaap:TrademarksAndTradeNamesMember2020-12-310001306830us-gaap:TrademarksAndTradeNamesMember2021-01-012021-09-300001306830us-gaap:TrademarksAndTradeNamesMember2021-09-30xbrli:pure0001306830ce:SeniorUnsecuredNotesDue2021Member2021-09-300001306830ce:SeniorUnsecuredNotesDue2021Member2020-12-310001306830ce:SeniorUnsecuredNotesDue2022Member2021-09-300001306830ce:SeniorUnsecuredNotesDue2022Member2020-12-310001306830ce:SeniorUnsecuredNotesDue2023Member2021-09-300001306830ce:SeniorUnsecuredNotesDue2023Member2020-12-310001306830ce:SeniorUnsecuredNotesDue2024Member2021-09-300001306830ce:SeniorUnsecuredNotesDue2024Member2020-12-310001306830ce:SeniorUnsecuredNotesDue2025Member2021-09-300001306830ce:SeniorUnsecuredNotesDue2025Member2020-12-310001306830ce:SeniorUnsecuredNotesDue2026Member2021-09-300001306830ce:SeniorUnsecuredNotesDue2026Member2020-12-310001306830ce:SeniorUnsecuredNotesDue2027Member2021-09-300001306830ce:SeniorUnsecuredNotesDue2027Member2020-12-310001306830ce:SeniorUnsecuredNotesDue2028DEPRMember2021-09-300001306830ce:SeniorUnsecuredNotesDue2028DEPRMember2020-12-310001306830srt:MinimumMemberce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2021-09-300001306830srt:MaximumMemberce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2021-09-300001306830ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2021-09-300001306830ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2020-12-310001306830us-gaap:LoansPayableMember2021-09-300001306830us-gaap:LoansPayableMember2020-12-310001306830us-gaap:RevolvingCreditFacilityMemberce:SeniorUnsecuredRevolvingCreditFacilityMember2021-09-300001306830us-gaap:RevolvingCreditFacilityMember2021-01-012021-09-300001306830us-gaap:RevolvingCreditFacilityMemberce:SeniorUnsecuredRevolvingCreditFacilityMember2021-01-012021-09-300001306830us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberce:SeniorUnsecuredRevolvingCreditFacilityMember2021-09-302021-09-300001306830ce:SeniorUnsecuredNotesDue2026Member2021-08-050001306830us-gaap:RevolvingCreditFacilityMemberce:SeniorUnsecuredRevolvingCreditFacilityMember2021-08-052021-08-05iso4217:EUR0001306830ce:SeniorUnsecuredNotesDue2028Member2021-09-100001306830ce:SeniorUnsecuredNotesDue2028DEPRMember2021-09-100001306830ce:SeniorUnsecuredNotesDue2023Member2021-09-130001306830ce:SeniorUnsecuredNotesDue2023Member2021-09-132021-09-130001306830ce:SeniorUnsecuredNotesDue2023Member2021-01-012021-09-300001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2021-01-012021-09-300001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2021-09-300001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2020-12-310001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2021-01-012021-09-300001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2020-01-012020-12-310001306830ce:EuropeAndSingaporeFactoringAgreementsMember2021-09-300001306830ce:EuropeAndSingaporeFactoringAgreementsMember2020-12-310001306830ce:EuropeAndSingaporeFactoringAgreementsMember2021-01-012021-09-300001306830ce:EuropeAndSingaporeFactoringAgreementsMember2020-01-012020-12-310001306830ce:SingaporeDiscountingAgreementMember2021-09-300001306830us-gaap:PensionPlansDefinedBenefitMember2021-07-012021-09-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-07-012021-09-300001306830us-gaap:PensionPlansDefinedBenefitMember2020-07-012020-09-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-07-012020-09-300001306830us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-09-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-09-300001306830us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-09-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-09-300001306830us-gaap:PensionPlansDefinedBenefitMember2021-09-300001306830us-gaap:OtherPensionPlansDefinedBenefitMember2021-01-012021-09-300001306830us-gaap:OtherPensionPlansDefinedBenefitMember2021-09-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-09-300001306830us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2021-01-012021-09-300001306830us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2021-09-300001306830ce:PassaicRiverNewJerseyMember2021-01-012021-09-300001306830ce:PassaicRiverNewJerseyMember2016-03-312016-03-310001306830ce:PassaicRiverNewJerseyMember2021-09-3000013068302021-07-142021-07-140001306830us-gaap:SubsequentEventMember2021-10-202021-10-2000013068302008-02-012021-09-300001306830us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001306830us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-09-300001306830us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-09-300001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-09-300001306830us-gaap:AccumulatedTranslationAdjustmentMember2021-09-300001306830us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-09-300001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-300001306830srt:EuropeMemberce:EngineeredMaterialsMember2020-01-012020-09-300001306830ce:LebanonTennesseeMemberce:EngineeredMaterialsMember2020-01-012020-09-300001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2020-12-310001306830us-gaap:EmployeeSeveranceMemberce:AcetateTowMember2020-12-310001306830us-gaap:EmployeeSeveranceMemberce:AcetylChainMember2020-12-310001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2020-12-310001306830us-gaap:EmployeeSeveranceMember2020-12-310001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2021-01-012021-09-300001306830us-gaap:EmployeeSeveranceMemberce:AcetateTowMember2021-01-012021-09-300001306830us-gaap:EmployeeSeveranceMemberce:AcetylChainMember2021-01-012021-09-300001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2021-01-012021-09-300001306830us-gaap:EmployeeSeveranceMember2021-01-012021-09-300001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2021-09-300001306830us-gaap:EmployeeSeveranceMemberce:AcetateTowMember2021-09-300001306830us-gaap:EmployeeSeveranceMemberce:AcetylChainMember2021-09-300001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2021-09-300001306830us-gaap:EmployeeSeveranceMember2021-09-300001306830us-gaap:NetInvestmentHedgingMember2021-01-012021-09-300001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2021-09-302021-09-300001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2020-12-312020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-01-012021-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2020-12-310001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-08-022021-08-020001306830us-gaap:NondesignatedMember2021-01-012021-09-300001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-09-300001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2021-07-012021-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2020-07-012020-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-07-012021-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2020-07-012020-09-300001306830us-gaap:CashFlowHedgingMember2021-07-012021-09-300001306830us-gaap:CashFlowHedgingMember2020-07-012020-09-300001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2021-07-012021-09-300001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2020-07-012020-09-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2021-07-012021-09-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2020-07-012020-09-300001306830us-gaap:NetInvestmentHedgingMember2021-07-012021-09-300001306830us-gaap:NetInvestmentHedgingMember2020-07-012020-09-300001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-07-012021-09-300001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-07-012020-09-300001306830us-gaap:NondesignatedMember2021-07-012021-09-300001306830us-gaap:NondesignatedMember2020-07-012020-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2021-01-012021-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2020-01-012020-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2021-01-012021-09-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2020-01-012020-09-300001306830us-gaap:CashFlowHedgingMember2021-01-012021-09-300001306830us-gaap:CashFlowHedgingMember2020-01-012020-09-300001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2021-01-012021-09-300001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2020-01-012020-09-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2021-01-012021-09-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2020-01-012020-09-300001306830us-gaap:NetInvestmentHedgingMember2020-01-012020-09-300001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-01-012021-09-300001306830us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-01-012020-09-300001306830us-gaap:NondesignatedMember2020-01-012020-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMember2021-09-300001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2021-09-300001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMember2021-09-300001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-09-300001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-09-300001306830us-gaap:FairValueMeasurementsRecurringMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2021-09-300001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentLiabilitiesMember2021-09-300001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2021-09-300001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMember2021-09-300001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMember2020-12-310001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMember2020-12-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001306830us-gaap:FairValueMeasurementsRecurringMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel1Member2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2020-12-310001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentLiabilitiesMember2020-12-310001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2020-12-310001306830us-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMember2020-12-310001306830us-gaap:FairValueInputsLevel2Member2021-09-300001306830us-gaap:FairValueInputsLevel3Member2021-09-300001306830us-gaap:FairValueInputsLevel2Member2020-12-310001306830us-gaap:FairValueInputsLevel3Member2020-12-310001306830ce:IndemnificationAgreementsHoechstMember2021-09-300001306830ce:IndemnificationAgreementsHoechstMember1999-11-012021-09-300001306830ce:DivestitureAgreementsMember2021-09-300001306830ce:EuropeanCommissionCompetitionLawInvestigationMember2019-12-310001306830us-gaap:SettledLitigationMemberce:EuropeanCommissionCompetitionLawInvestigationMember2019-10-012020-06-300001306830us-gaap:SettledLitigationMemberce:EuropeanCommissionCompetitionLawInvestigationMember2021-01-122021-01-120001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2021-07-012021-09-300001306830ce:AcetateTowMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300001306830us-gaap:OperatingSegmentsMemberce:AcetylChainMember2021-07-012021-09-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2021-07-012021-09-300001306830us-gaap:IntersegmentEliminationMember2021-07-012021-09-300001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2020-07-012020-09-300001306830ce:AcetateTowMemberus-gaap:OperatingSegmentsMember2020-07-012020-09-300001306830us-gaap:OperatingSegmentsMemberce:AcetylChainMember2020-07-012020-09-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2020-07-012020-09-300001306830us-gaap:IntersegmentEliminationMember2020-07-012020-09-300001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2021-01-012021-09-300001306830ce:AcetateTowMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300001306830us-gaap:OperatingSegmentsMemberce:AcetylChainMember2021-01-012021-09-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2021-01-012021-09-300001306830us-gaap:IntersegmentEliminationMember2021-01-012021-09-300001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2021-09-300001306830ce:AcetateTowMemberus-gaap:OperatingSegmentsMember2021-09-300001306830us-gaap:OperatingSegmentsMemberce:AcetylChainMember2021-09-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2021-09-300001306830us-gaap:IntersegmentEliminationMember2021-09-300001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2020-01-012020-09-300001306830ce:AcetateTowMemberus-gaap:OperatingSegmentsMember2020-01-012020-09-300001306830us-gaap:OperatingSegmentsMemberce:AcetylChainMember2020-01-012020-09-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2020-01-012020-09-300001306830us-gaap:IntersegmentEliminationMember2020-01-012020-09-300001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2020-12-310001306830ce:AcetateTowMemberus-gaap:OperatingSegmentsMember2020-12-310001306830us-gaap:OperatingSegmentsMemberce:AcetylChainMember2020-12-310001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2020-12-310001306830us-gaap:IntersegmentEliminationMember2020-12-3100013068302021-10-012021-09-3000013068302022-01-012021-09-3000013068302023-01-012021-09-300001306830srt:NorthAmericaMemberce:EngineeredMaterialsMember2021-07-012021-09-300001306830srt:NorthAmericaMemberce:EngineeredMaterialsMember2020-07-012020-09-300001306830srt:NorthAmericaMemberce:EngineeredMaterialsMember2021-01-012021-09-300001306830srt:NorthAmericaMemberce:EngineeredMaterialsMember2020-01-012020-09-300001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2021-07-012021-09-300001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2020-07-012020-09-300001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2021-01-012021-09-300001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2020-01-012020-09-300001306830srt:AsiaPacificMemberce:EngineeredMaterialsMember2021-07-012021-09-300001306830srt:AsiaPacificMemberce:EngineeredMaterialsMember2020-07-012020-09-300001306830srt:AsiaPacificMemberce:EngineeredMaterialsMember2021-01-012021-09-300001306830srt:AsiaPacificMemberce:EngineeredMaterialsMember2020-01-012020-09-300001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2021-07-012021-09-300001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2020-07-012020-09-300001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2021-01-012021-09-300001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2020-01-012020-09-300001306830ce:EngineeredMaterialsMember2021-07-012021-09-300001306830ce:EngineeredMaterialsMember2020-07-012020-09-300001306830ce:EngineeredMaterialsMember2020-01-012020-09-300001306830ce:AcetateTowMembersrt:NorthAmericaMember2021-07-012021-09-300001306830ce:AcetateTowMembersrt:NorthAmericaMember2020-07-012020-09-300001306830ce:AcetateTowMembersrt:NorthAmericaMember2021-01-012021-09-300001306830ce:AcetateTowMembersrt:NorthAmericaMember2020-01-012020-09-300001306830ce:AcetateTowMemberus-gaap:EMEAMember2021-07-012021-09-300001306830ce:AcetateTowMemberus-gaap:EMEAMember2020-07-012020-09-300001306830ce:AcetateTowMemberus-gaap:EMEAMember2021-01-012021-09-300001306830ce:AcetateTowMemberus-gaap:EMEAMember2020-01-012020-09-300001306830ce:AcetateTowMembersrt:AsiaPacificMember2021-07-012021-09-300001306830ce:AcetateTowMembersrt:AsiaPacificMember2020-07-012020-09-300001306830ce:AcetateTowMembersrt:AsiaPacificMember2021-01-012021-09-300001306830ce:AcetateTowMembersrt:AsiaPacificMember2020-01-012020-09-300001306830ce:AcetateTowMembersrt:SouthAmericaMember2021-07-012021-09-300001306830ce:AcetateTowMembersrt:SouthAmericaMember2020-07-012020-09-300001306830ce:AcetateTowMembersrt:SouthAmericaMember2021-01-012021-09-300001306830ce:AcetateTowMembersrt:SouthAmericaMember2020-01-012020-09-300001306830ce:AcetateTowMember2021-07-012021-09-300001306830ce:AcetateTowMember2020-07-012020-09-300001306830ce:AcetateTowMember2020-01-012020-09-300001306830srt:NorthAmericaMemberce:AcetylChainMember2021-07-012021-09-300001306830srt:NorthAmericaMemberce:AcetylChainMember2020-07-012020-09-300001306830srt:NorthAmericaMemberce:AcetylChainMember2021-01-012021-09-300001306830srt:NorthAmericaMemberce:AcetylChainMember2020-01-012020-09-300001306830us-gaap:EMEAMemberce:AcetylChainMember2021-07-012021-09-300001306830us-gaap:EMEAMemberce:AcetylChainMember2020-07-012020-09-300001306830us-gaap:EMEAMemberce:AcetylChainMember2021-01-012021-09-300001306830us-gaap:EMEAMemberce:AcetylChainMember2020-01-012020-09-300001306830srt:AsiaPacificMemberce:AcetylChainMember2021-07-012021-09-300001306830srt:AsiaPacificMemberce:AcetylChainMember2020-07-012020-09-300001306830srt:AsiaPacificMemberce:AcetylChainMember2021-01-012021-09-300001306830srt:AsiaPacificMemberce:AcetylChainMember2020-01-012020-09-300001306830srt:SouthAmericaMemberce:AcetylChainMember2021-07-012021-09-300001306830srt:SouthAmericaMemberce:AcetylChainMember2020-07-012020-09-300001306830srt:SouthAmericaMemberce:AcetylChainMember2021-01-012021-09-300001306830srt:SouthAmericaMemberce:AcetylChainMember2020-01-012020-09-300001306830ce:AcetylChainMember2021-07-012021-09-300001306830ce:AcetylChainMember2020-07-012020-09-300001306830ce:AcetylChainMember2020-01-012020-09-300001306830us-gaap:IntersegmentEliminationMemberce:AcetylChainMember2021-07-012021-09-300001306830us-gaap:IntersegmentEliminationMemberce:AcetylChainMember2020-07-012020-09-300001306830us-gaap:IntersegmentEliminationMemberce:AcetylChainMember2021-01-012021-09-300001306830us-gaap:IntersegmentEliminationMemberce:AcetylChainMember2020-01-012020-09-30 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ? OF 1934 For the quarterly period ended September 30, 2021 Or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ? OF 1934 Commission File Number: 001-32410 [[Image Removed: ce-20210930_g1.gif]] CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 98-0420726 (State or Other Jurisdiction of Incorporation or (I.R.S. Employer Identification Organization) No.) 222 W. Las Colinas Blvd., Suite 900N Irving, TX 75039-5421 (Address of Principal Executive Offices and zip code) (972) 443-4000 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of Each Exchange on Which Title of Each Class Trading Symbol(s) Registered Common Stock, par value $0.0001 per The New York Stock Exchange share CE 1.125% Senior Notes due 2023 CE /23 The New York Stock Exchange 1.250% Senior Notes due 2025 CE /25 The New York Stock Exchange 2.125% Senior Notes due 2027 CE /27 The New York Stock Exchange 0.625% Senior Notes due 2028 CE /28 The New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ? No ? Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ? No ? Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer þ Accelerated filer ? Non-accelerated filer ? Smaller reporting company ? Emerging growth company ? If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ? Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ? No ? The number of outstanding shares of the registrant's common stock, $0.0001 par value, as of October 15, 2021 was 108,870,848. -------------------------------------------------------------------------------- Table of Contents CELANESE CORPORATION AND SUBSIDIARIES Form 10-Q For the Quarterly Period Ended September 30, 2021 TABLE OF CONTENTS Page PART I - FINANCIAL INFORMATION Item 1. Financial Statements 3 a) Unaudited Interim Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020 3 b) Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2021 and 2020 4 c) Unaudited Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020 5 d) Unaudited Interim Consolidated Statements of Equity for the three and nine months ended September 30, 2021 and 2020 6 e) Unaudited Interim Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 8 f) Notes to the Unaudited Interim Consolidated Financial Statements 9 Management's Discussion and Analysis of Financial Condition and Results of Item 2. Operations 32 Item 3. Quantitative and Qualitative Disclosures about Market Risk 48 Item 4. Controls and Procedures 49 PART II - OTHER INFORMATION Item 1. Legal Proceedings 50 Item 1A. Risk Factors 50 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 50 Item 3. Defaults Upon Senior Securities 50 Item 4. Mine Safety Disclosures 50 Item 5. Other Information 50 Item 6. Exhibits 51 Signatures 52 2 -------------------------------------------------------------------------------- Table of Contents Item 1. Financial Statements CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 (In $ millions, except share and per share data) Net sales 2,266 1,411 6,262 4,064 Cost of sales (1,551) (1,084) (4,301) (3,147) Gross profit 715 327 1,961 917 Selling, general and administrative expenses (165) (106) (463) (345) Amortization of intangible assets (6) (6) (17) (17) Research and development expenses (21) (19) (63) (54) Other (charges) gains, net — (10) 3 (37) Foreign exchange gain (loss), net 2 (2) 2 (2) Gain (loss) on disposition of businesses and assets, net 11 — 6 (1) Operating profit (loss) 536 184 1,429 461 Equity in net earnings (loss) of affiliates 44 25 110 113 Non-operating pension and other postretirement employee benefit (expense) income 37 28 113 83 Interest expense (21) (28) (70) (83) Refinancing expense (9) — (9) — Interest income 2 1 7 4 Dividend income - equity investments 35 29 114 98 Other income (expense), net (2) 2 (3) 4 Earnings (loss) from continuing operations before tax 622 241 1,691 680 Income tax (provision) benefit (102) (30) (303) (130) Earnings (loss) from continuing operations 520 211 1,388 550 Earnings (loss) from operation of discontinued operations (17) (2) (24) (13) Income tax (provision) benefit from discontinued operations 4 — 6 1 Earnings (loss) from discontinued operations (13) (2) (18) (12) Net earnings (loss) 507 209 1,370 538 Net (earnings) loss attributable to noncontrolling interests (1) (2) (4) (6) Net earnings (loss) attributable to Celanese Corporation 506 207 1,366 532 Amounts attributable to Celanese Corporation Earnings (loss) from continuing operations 519 209 1,384 544 Earnings (loss) from discontinued operations (13) (2) (18) (12) Net earnings (loss) 506 207 1,366 532 Earnings (loss) per common share - basic Continuing operations 4.70 1.77 12.35 4.59 Discontinued operations (0.12) (0.02) (0.16) (0.10) Net earnings (loss) - basic 4.58 1.75 12.19 4.49 Earnings (loss) per common share - diluted Continuing operations 4.67 1.76 12.28 4.57 Discontinued operations (0.11) (0.01) (0.16) (0.10) Net earnings (loss) - diluted 4.56 1.75 12.12 4.47 Weighted average shares - basic 110,532,051 118,045,476 112,101,651 118,543,853 Weighted average shares - diluted 111,044,558 118,564,820 112,699,297 119,119,203 See the accompanying notes to the unaudited interim consolidated financial statements. 3 -------------------------------------------------------------------------------- Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 (In $ millions) Net earnings (loss) 507 209 1,370 538 Other comprehensive income (loss), net of tax Foreign currency translation gain (loss) (15) (3) (12) (11) Gain (loss) on cash flow hedges (15) 5 16 (33) Pension and postretirement benefits — — (4) — Total other comprehensive income (loss), net of tax (30) 2 — (44) Total comprehensive income (loss), net of tax 477 211 1,370 494 Comprehensive (income) loss attributable to noncontrolling interests (1) (2) (4) (6) Comprehensive income (loss) attributable to Celanese Corporation 476 209 1,366 488 See the accompanying notes to the unaudited interim consolidated financial statements. 4 -------------------------------------------------------------------------------- Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED BALANCE SHEETS As of As of September 30, December 31, 2021 2020 (In $ millions, except share data) ASSETS Current Assets Cash and cash equivalents 1,340 955 Trade receivables - third party and affiliates 1,172 792 Non-trade receivables, net 566 450 Inventories 1,159 978 Marketable securities 28 533 Other assets 90 55 Total current assets 4,355 3,763 Investments in affiliates 842 820 Property, plant and equipment (net of accumulated depreciation - 2021: $3,424; 2020: $3,279) 3,924 3,939 Operating lease right-of-use assets 231 232 Deferred income taxes 254 259 Other assets 543 411 Goodwill 1,131 1,166 Intangible assets, net 303 319 Total assets 11,583 10,909 LIABILITIES AND EQUITY Current Liabilities Short-term borrowings and current installments of long-term debt - third party and affiliates 103 496 Trade payables - third party and affiliates 1,042 797 Other liabilities 529 680 Income taxes payable 138 — Total current liabilities 1,812 1,973 Long-term debt, net of unamortized deferred financing costs 3,724 3,227 Deferred income taxes 537 509 Uncertain tax positions 272 240 Benefit obligations 592 643 Operating lease liabilities 197 208 Other liabilities 178 214 Commitments and Contingencies Stockholders' Equity Preferred stock, $0.01 par value, 100,000,000 shares authorized (2021 and 2020: 0 issued and outstanding) — — Common stock, $0.0001 par value, 400,000,000 shares authorized (2021: 169,720,379 issued and 109,180,323 outstanding; 2020: 169,402,979 issued and 114,168,464 outstanding) — — Treasury stock, at cost (2021: 60,540,056 shares; 2020: 55,234,515 shares) (5,293) (4,494) Additional paid-in capital 313 257 Retained earnings 9,227 8,091 Accumulated other comprehensive income (loss), net (328) (328) Total Celanese Corporation stockholders' equity 3,919 3,526 Noncontrolling interests 352 369 Total equity 4,271 3,895 Total liabilities and equity 11,583 10,909 See the accompanying notes to the unaudited interim consolidated financial statements. 5 -------------------------------------------------------------------------------- Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY Three Months Ended September 30, 2021 2020 Shares Amount Shares Amount (In $ millions, except share data) Common Stock Balance as of the beginning of the period 111,115,442 — 118,288,296 — Purchases of treasury stock (1,938,179) — (1,060,890) — Stock awards 3,060 — 2,383 — Balance as of the end of the period 109,180,323 — 117,229,789 — Treasury Stock Balance as of the beginning of the period 58,601,877 (4,993) 51,083,026 (3,995) Purchases of treasury stock, including related fees 1,938,179 (300) 1,060,890 (111) Balance as of the end of the period 60,540,056 (5,293) 52,143,916 (4,106) Additional Paid-In Capital Balance as of the beginning of the period 292 252 Stock-based compensation, net of tax 21 (4) Balance as of the end of the period 313 248 Retained Earnings Balance as of the beginning of the period 8,797 6,576 Net earnings (loss) attributable to Celanese Corporation 506 207 Common stock dividends (76) (73) Balance as of the end of the period 9,227 6,710 Accumulated Other Comprehensive Income (Loss), Net Balance as of the beginning of the period (298) (346) Other comprehensive income (loss), net of tax (30) 2 Balance as of the end of the period (328) (344) Total Celanese Corporation stockholders' equity 3,919 2,508 Noncontrolling Interests Balance as of the beginning of the period 359 382 Net earnings (loss) attributable to noncontrolling interests 1 2 Distributions to noncontrolling interests (8) (8) Balance as of the end of the period 352 376 Total equity 4,271 2,884 See the accompanying notes to the unaudited interim consolidated financial statements. 6 -------------------------------------------------------------------------------- Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY Nine Months Ended September 30, 2021 2020 Shares Amount Shares Amount (In $ millions, except share data) Common Stock Balance as of the beginning of the period 114,168,464 — 119,555,207 — Purchases of treasury stock (5,332,727) — (2,770,321) — Stock awards 344,586 — 444,903 — Balance as of the end of the period 109,180,323 — 117,229,789 — Treasury Stock Balance as of the beginning of the period 55,234,515 (4,494) 49,417,965 (3,846) Purchases of treasury stock, including related fees 5,332,727 (800) 2,770,321 (261) Issuance of treasury stock under stock plans (27,186) 1 (44,370) 1 Balance as of the end of the period 60,540,056 (5,293) 52,143,916 (4,106) Additional Paid-In Capital Balance as of the beginning of the period 257 254 Stock-based compensation, net of tax 56 (6) Balance as of the end of the period 313 248 Retained Earnings Balance as of the beginning of the period 8,091 6,399 Net earnings (loss) attributable to Celanese Corporation 1,366 532 Common stock dividends (230) (221) Balance as of the end of the period 9,227 6,710 Accumulated Other Comprehensive Income (Loss), Net Balance as of the beginning of the period (328) (300) Other comprehensive income (loss), net of tax — (44) Balance as of the end of the period (328) (344) Total Celanese Corporation stockholders' equity 3,919 2,508 Noncontrolling Interests Balance as of the beginning of the period 369 391 Net earnings (loss) attributable to noncontrolling interests 4 6 Distributions to noncontrolling interests (21) (21) Balance as of the end of the period 352 376 Total equity 4,271 2,884 See the accompanying notes to the unaudited interim consolidated financial statements. 7 -------------------------------------------------------------------------------- Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS Nine Months Ended September 30, 2021 2020 (In $ millions) Operating Activities Net earnings (loss) 1,370 538 Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities Asset impairments 2 31 Depreciation, amortization and accretion 278 265 Pension and postretirement net periodic benefit cost (102) (74) Pension and postretirement contributions (36) (35) Deferred income taxes, net 9 (90) (Gain) loss on disposition of businesses and assets, net (7) 1 Stock-based compensation 76 17 Undistributed earnings in unconsolidated affiliates (48) (2) Other, net 21 15 Operating cash provided by (used in) discontinued operations 14 7 Changes in operating assets and liabilities Trade receivables - third party and affiliates, net (402) 196 Inventories (207) 78 Other assets (150) 68 Trade payables - third party and affiliates 259 (57) Other liabilities 96 111 Net cash provided by (used in) operating activities 1,173 1,069 Investing Activities Capital expenditures on property, plant and equipment (304) (279) Acquisitions, net of cash acquired (15) (100) Proceeds from sale of businesses and assets, net 22 17 Proceeds from sale of marketable securities 500 — Other, net (36) (25) Net cash provided by (used in) investing activities 167 (387) Financing Activities Net change in short-term borrowings with maturities of 3 months or less 17 170 Proceeds from short-term borrowings — 306 Repayments of short-term borrowings (6) (452) Proceeds from long-term debt 991 — Repayments of long-term debt (778) (23) Purchases of treasury stock, including related fees (803) (272) Common stock dividends (230) (221) Distributions to noncontrolling interests (21) (21) Settlement of forward-starting interest rate swaps (72) — Other, net (41) (25) Net cash provided by (used in) financing activities (943) (538) Exchange rate effects on cash and cash equivalents (12) 8 Net increase (decrease) in cash and cash equivalents 385 152 Cash and cash equivalents as of beginning of period 955 463 Cash and cash equivalents as of end of period 1,340 615 See the accompanying notes to the unaudited interim consolidated financial statements. 8 -------------------------------------------------------------------------------- Table of Contents CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS 1. Description of the Company and Basis of Presentation Description of the Company Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles. Definitions In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese U.S. Holdings LLC, a Delaware limited liability company, and not its subsidiaries. Basis of Presentation The unaudited interim consolidated financial statements for the three and nine months ended September 30, 2021 and 2020 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations. In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2020, filed on February 11, 2021 with the SEC as part of the Company's Annual Report on Form 10-K. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire year. In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report. For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as noncontrolling interests. Estimates and Assumptions The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension 9 -------------------------------------------------------------------------------- Table of Contents and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. 2. Recent Accounting Pronouncements The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the Financial Accounting Standards Board ("FASB"): Effect on the Financial Statements or Other Significant Standard Description Effective Date Matters In March 2020, the FASB The new guidance provides March 12, 2020 through The Company has completed its issued ASU 2020-04, optional expedients and December 31, 2022. assessment, and the adoption of Facilitation of the exceptions for applying U.S. the new guidance did not have a Effects of Reference GAAP to contracts, hedging material impact to the Company. Rate Reform on Financial relationships and other Reporting. transactions affected by reference rate reform if certain criteria are met. The guidance applies only to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In December 2019, the The new guidance simplifies January 1, 2021. The Company adopted the new FASB issued ASU 2019-12, the accounting for income guidance effective Simplifying the taxes by removing certain January 1, 2021. The adoption of Accounting for Income exceptions to the general the new guidance did not have a Taxes. principles in FASB Accounting material impact to the Company. Standards Codification Topic 740, Income Taxes ("Topic 740"). The guidance also clarifies and amends existing guidance under Topic 740. 3. Acquisitions, Dispositions and Plant Closures Acquisition On June 30, 2021, the Company signed a definitive agreement to acquire the Santoprene™ thermoplastic vulcanizates ("TPV") elastomers business of Exxon Mobil Corporation for a purchase price of $1.15 billion in an all-cash transaction. The Company will acquire the Santoprene™, Dytron™ and Geolast™ trademarks and product portfolios, customer and supplier contracts and agreements, both production facilities producing Santoprene, the TPV intellectual property portfolio with associated technical and R&D assets and employees of the TPV elastomer business. The acquired operations will be included in the Engineered Materials segment. The Company expects the acquisition to close in the fourth quarter of 2021, subject to regulatory approvals, carve-out preparations and other customary closing conditions. Plant Closures • European Compounding Center of Excellence In July 2020, the Company announced that it is establishing a European Compounding Center of Excellence at its Forli, Italy facility, which includes the intended consolidation of its compounding operations in Kaiserslautern, Germany; Wehr, Germany; and Ferrara Marconi, Italy. These operations are included in the Company's Engineered Materials segment. The Company expects to complete the consolidation of the compounding operations by the end of 2022. 10 -------------------------------------------------------------------------------- Table of Contents The exit and shutdown costs related to the Forli, Italy consolidation were as follows: Nine Months Ended September 30, 2021 (In $ millions) Accelerated depreciation expense 5 Plant/office closures(1) (9) Total (4) ______________________________ (1)Included in Other (charges) gains, net in the unaudited interim consolidated statement of operations ( Note 12 ). The Company expects to incur additional exit and shutdown costs related to the Forli, Italy consolidation of approximately $12 million through 2022. 4. Inventories As of As of September 30, December 31, 2021 2020 (In $ millions) Finished goods 736 653 Work-in-process 74 74 Raw materials and supplies 349 251 Total 1,159 978 5. Goodwill and Intangible Assets, Net Goodwill Engineered Materials Acetate Tow Acetyl Chain Total (In $ millions) As of December 31, 2020 768 149 249 1,166 Acquisitions 4 — 2 6 Exchange rate changes (28) — (13) (41) As of September 30, 2021(1) 744 149 238 1,131 ______________________________ (1)There were no accumulated impairment losses as of September 30, 2021. The Company assesses the recoverability of the carrying amount of its reporting unit goodwill either qualitatively or quantitatively annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. In connection with the Company's annual goodwill impairment assessment, the Company did not record an impairment loss to goodwill during the nine months ended September 30, 2021 as the estimated fair value for each of the Company's reporting units exceeded the carrying amount of the underlying assets by a substantial margin. 11 -------------------------------------------------------------------------------- Table of Contents Intangible Assets, Net Finite-lived intangible assets are as follows: Customer- Covenants Related Not to Intangible Developed Compete Licenses Assets Technology and Other Total (In $ millions) Gross Asset Value As of December 31, 2020 44 724 45 56 869 Acquisitions — 8 — — 8 Exchange rate changes — (26) (1) — (27) As of September 30, 2021 44 706 44 56 850 Accumulated Amortization As of December 31, 2020 (38) (555) (40) (39) (672) Amortization (1) (13) (2) (1) (17) Exchange rate changes — 23 1 — 24 As of September 30, 2021 (39) (545) (41) (40) (665) Net book value 5 161 3 16 185 Indefinite-lived intangible assets are as follows: Trademarks and Trade Names (In $ millions) As of December 31, 2020 122 Exchange rate changes (4) As of September 30, 2021 118 The Company assesses the recoverability of the carrying amount of its indefinite-lived intangible assets either qualitatively or quantitatively annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. In connection with the Company's annual indefinite-lived intangible assets impairment assessment, the Company did not record an impairment loss to indefinite-lived intangible assets during the nine months ended September 30, 2021 as the estimated fair value of each of the Company's indefinite-lived intangible assets exceeded the carrying value of the underlying assets by a substantial margin. During the nine months ended September 30, 2021, the Company did not renew or extend any intangible assets. Estimated amortization expense for the succeeding five fiscal years is as follows: (In $ millions) 2022 22 2023 20 2024 19 2025 19 2026 18 12 -------------------------------------------------------------------------------- Table of Contents 6. Current Other Liabilities As of As of September 30, December 31, 2021 2020 (In $ millions) Asset retirement obligations 12 10 Benefit obligations ( Note 9 ) 27 27 Customer rebates 72 53 Derivatives ( Note 14 ) 9 87 Environmental ( Note 10 ) 14 11 Insurance 6 5 Interest 22 29 Legal ( Note 16 ) 33 107 Operating leases 35 36 Restructuring ( Note 12 ) 8 11 Salaries and benefits 139 121 Sales and use tax/foreign withholding tax payable 110 140 Other 42 43 Total 529 680 7. Noncurrent Other Liabilities As of As of September 30, December 31, 2021 2020 (In $ millions) Asset retirement obligations 13 10 Deferred proceeds 44 47 Deferred revenue ( Note 18 ) 4 4 Derivatives ( Note 14 ) 9 34 Environmental ( Note 10 ) 45 58 Insurance 38 33 Other 25 28 Total 178 214 13 -------------------------------------------------------------------------------- Table of Contents 8. Debt As of As of September 30, December 31, 2021 2020 (In $ millions) Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates Current installments of long-term debt 28 431 Short-term borrowings, including amounts due to affiliates(1) 75 65 Total 103 496 ______________________________ (1)The weighted average interest rate was 0.2% and 0.6% as of September 30, 2021 and December 31, 2020, respectively. As of As of September 30, December 31, 2021 2020 (In $ millions) Long-Term Debt Senior unsecured notes due 2021, interest rate of 5.875% — 400 Senior unsecured notes due 2022, interest rate of 4.625% 500 500 Senior unsecured notes due 2023, interest rate of 1.125% 521 919 Senior unsecured notes due 2024, interest rate of 3.500% 499 499 Senior unsecured notes due 2025, interest rate of 1.250% 347 368 Senior unsecured notes due 2026, interest rate of 1.400% 400 — Senior unsecured notes due 2027, interest rate of 2.125% 576 610 Senior unsecured notes due 2028, interest rate of 0.625% 578 — Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00% 166 166 Bank loans due at various dates through 2026(1) 6 8 Obligations under finance leases due at various dates through 2054 179 201 Subtotal 3,772 3,671 Unamortized debt issuance costs(2) (20) (13) Current installments of long-term debt (28) (431) Total 3,724 3,227 ______________________________ (1)The weighted average interest rate was 1.3% and 1.3% as of September 30, 2021 and December 31, 2020, respectively. (2)Related to the Company's long-term debt, excluding obligations under finance leases. Senior Credit Facilities The Company has a senior credit agreement (the "Credit Agreement") consisting of a $1.25 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2024. The Credit Agreement is guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations ("the Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report. 14 -------------------------------------------------------------------------------- Table of Contents The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facility are as follows: As of September 30, 2021 (In $ millions) Revolving Credit Facility Borrowings outstanding(1) — Available for borrowing(2) 1,250 ______________________________ (1)The Company borrowed $400 million under its senior unsecured revolving credit facility to repay the 5.875% senior unsecured notes due June 15, 2021 and repaid $400 million under its senior unsecured revolving credit facility during the nine months ended September 30, 2021. (2)The margin for borrowings under the senior unsecured revolving credit facility was 1.25% above LIBOR or EURIBOR at current Company credit ratings. Senior Notes The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date. On August 5, 2021, Celanese U.S. completed an offering of $400 million in principal amount of 1.400% senior unsecured notes due August 5, 2026 (the "1.400% Notes") in a public offering registered under the Securities Act. The 1.400% Notes were issued at a discount to par at a price of 99.899%, which is being amortized to Interest expense in the unaudited interim consolidated statement of operations over the term of the 1.400% Notes. Net proceeds from the sale of the 1.400% Notes were used to repay $396 million of outstanding borrowings under the senior unsecured revolving credit facility and for general corporate purposes. On September 10, 2021, Celanese U.S. completed an offering of €500 million in principal amount of 0.625% senior unsecured notes due September 10, 2028 (the "0.625% Notes") in a public offering registered under the Securities Act. The 0.625% Notes were issued at a discount to par at a price of 99.898%, which is being amortized to Interest expense in the unaudited interim consolidated statements of operations over the term of the 0.625% Notes. On September 13, 2021, Celanese U.S. completed a cash tender offer for €300 million in principal amount of 1.125% senior unsecured notes due September 26, 2023 (the "1.125% Notes") at a purchase price of €1,027.35 per €1,000 of principal amount plus accrued interest, for a total principal and premium payment of $363 million plus accrued interest of $4 million. A portion of the proceeds from the issuance of the 0.625% Notes were used to fund the tender offer for €300 million of the 1.125% Notes. As a result of the tender offer, the carrying value of the 1.125% Notes were reduced by $353 million. The Company recognized financing costs of $9 million, which are included in Refinancing expense in the unaudited interim consolidated statement of operations for the nine months ended September 30, 2021. 15 -------------------------------------------------------------------------------- Table of Contents Accounts Receivable Purchasing Facility On June 18, 2021, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2024. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $812 million and $595 million of accounts receivable under this agreement for the nine months ended September 30, 2021 and twelve months ended December 31, 2020, respectively, and collected $812 million and $476 million of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $116 million were pledged by the SPE as collateral to the Purchasers as of September 30, 2021. Factoring and Discounting Agreements The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $134 million and $233 million of accounts receivable under these factoring agreements for the nine months ended September 30, 2021 and twelve months ended December 31, 2020, respectively, and collected $133 million and $237 million of accounts receivable sold under these factoring agreements during the same periods. In March 2021, the Company entered into an agreement in Singapore with a financial institution to discount, on a non-recourse basis, documentary credits or other documents recorded as accounts receivable. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $57 million of accounts receivable under this agreement for the nine months ended September 30, 2021. Covenants The Company's material financing arrangements contain customary covenants, including the maintenance of certain financial ratios, events of default and change of control provisions. Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with all of the covenants related to its debt agreements as of September 30, 2021. 16 -------------------------------------------------------------------------------- Table of Contents 9. Benefit Obligations The components of net periodic benefit cost are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Pension Post-retirement Pension Post-retirement Pension Post-retirement Pension Post-retirement Benefits Benefits Benefits Benefits Benefits Benefits Benefits Benefits (In $ millions) Service cost 3 — 2 1 10 1 8 1 Interest cost 13 1 22 — 40 1 64 1 Expected return on plan assets (51) — (50) — (154) — (149) — Special termination benefit — — — — — — 1 — Total (35) 1 (26) 1 (104) 2 (76) 2 Benefit obligation funding is as follows: As of Total September 30, Expected 2021 2021 (In $ millions) Cash contributions to defined benefit pension plans 17 23 Benefit payments to nonqualified pension plans 16 20 Benefit payments to other postretirement benefit plans 3 4 Cash contributions to German multiemployer defined benefit pension plans(1) 6 9 ______________________________ (1)The Company makes contributions based on specified percentages of employee contributions. The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006. 10. Environmental The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies. 17 -------------------------------------------------------------------------------- Table of Contents The components of environmental remediation liabilities are as follows: As of As of September 30, December 31, 2021 2020 (In $ millions) Demerger obligations ( Note 16 ) 24 29 Divestiture obligations ( Note 16 ) 13 15 Active sites 8 12 U.S. Superfund sites 12 11 Other environmental remediation liabilities 2 2 Total 59 69 Remediation Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (as defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company ( Note 16 ). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period. U.S. Superfund Sites In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites. As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available. One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the Lower Passaic River Site and the Newark Bay Area. Work on the RI/FS is ongoing. 18 -------------------------------------------------------------------------------- Table of Contents In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273-JLL-JAD (U.S. District Court New Jersey), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs. The Company is vigorously defending these matters and currently believes that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, estimated at less than 1%, will not be material to the Company's results of operations, cash flows or financial position. The EPA has initiated settlement discussions with a subgroup of defendants, including Celanese. 11. Stockholders' Equity Common Stock The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing senior credit facility and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant. On July 14, 2021, the Company's Board of Directors approved a $1.0 billion increase in its Common Stock repurchase authorization. As of September 30, 2021, the Company had $1.3 billion remaining under the previous authorization. The Company also declared a quarterly cash dividend of $0.68 per share on its Common Stock on October 20, 2021, amounting to $74 million. The cash dividend will be paid on November 15, 2021 to holders of record as of November 1, 2021. Treasury Stock The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date. Total From Nine Months Ended February 2008 September 30, Through September 30, 2021 2020 2021 Shares repurchased 5,332,727 2,770,321 68,100,778 Average purchase price per share $ 150.02 $ 94.44 $ 82.27 Shares repurchased (in $ millions) $ 800 $ 261 $ 5,603 Aggregate Board of Directors repurchase authorizations during the period (in $ millions) $ 1,000 $ 500 $ 6,866 The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of stockholders' equity. 19 -------------------------------------------------------------------------------- Table of Contents Other Comprehensive Income (Loss), Net Three Months Ended September 30, 2021 2020 Income Income Tax Tax Gross (Provision) Net Gross (Provision) Net Amount Benefit Amount Amount Benefit Amount (In $ millions) Foreign currency translation gain (loss) (6) (9) (15) (10) 7 (3) Gain (loss) on cash flow hedges 1 (16) (15) 6 (1) 5 Total (5) (25) (30) (4) 6 2 Nine Months Ended September 30, 2021 2020 Income Income Tax Tax Gross (Provision) Net Gross (Provision) Net Amount Benefit Amount Amount Benefit Amount (In $ millions) Foreign currency translation gain (loss) 3 (15) (12) (10) (1) (11) Gain (loss) on cash flow hedges 41 (25) 16 (44) 11 (33) Pension and postretirement benefits gain (loss) (4) — (4) — — — Total 40 (40) — (54) 10 (44) Adjustments to Accumulated other comprehensive income (loss), net, are as follows: Gain (Loss) Pension Accumulated on Cash and Other Foreign Flow Postretirement Comprehensive Currency Hedges Benefits Gain (Loss) Income Translation Gain (Loss) ( Note 14 ) ( Note 9 ) (Loss), Net (In $ millions) As of December 31, 2020 (260) (56) (12) (328) Other comprehensive income (loss) before reclassifications 3 43 (4) 42 Amounts reclassified from accumulated other comprehensive income (loss) — (2) — (2) Income tax (provision) benefit (15) (25) — (40) As of September 30, 2021 (272) (40) (16) (328) 12. Other (Charges) Gains, Net Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 (In $ millions) Restructuring (1) (9) (5) (17) Asset impairments — (2) (2) (31) Plant/office closures 1 1 10 6 Commercial disputes — — — 6 European Commission investigation — — — (2) Other — — — 1 Total — (10) 3 (37) 20 -------------------------------------------------------------------------------- Table of Contents During the nine months ended September 30, 2021 and 2020, the Company recorded $5 million and $17 million, respectively, of employee termination benefits primarily related to Company-wide business optimization projects. During the nine months ended September 30, 2020, the Company recorded a $26 million long-lived asset impairment loss related to certain fixed assets used in compounding operations at its facilities in Kaiserslautern, Germany; Wehr, Germany and Ferrara Marconi, Italy ( Note 3 ). In addition, during the nine months ended September 30, 2020, the Company recorded a $4 million long-lived asset impairment loss related to the closure of its manufacturing operations in Lebanon, Tennessee. The long-lived asset impairment losses were measured at the date of impairment to write-down the related property, plant and equipment and were included in the Company's Engineered Materials segment. During the nine months ended September 30, 2021, the Company recorded a $9 million gain within plant/office closures related to the termination of its Ferrara Marconi, Italy office lease, which was included in the Company's Engineered Materials segment. The changes in the restructuring liabilities by business segment are as follows: Engineered Materials Acetate Tow Acetyl Chain Other Total (In $ millions) Employee Termination Benefits As of December 31, 2020 8 1 — 2 11 Additions 3 — — 2 5 Cash payments (4) — — (3) (7) Exchange rate changes (1) — — — (1) As of September 30, 2021 6 1 — 1 8 13. Income Taxes Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 (In percentages) Effective income tax rate 16 12 18 19 The effective income tax rate for the three months ended September 30, 2021, was higher compared to the same period in 2020, primarily due to increased earnings in high tax jurisdictions. The effective income tax rate for the nine months ended September 30, 2021, was lower compared to the same period in 2020, primarily due to non-recurring adjustments in the prior periods to uncertain tax positions due to available attribute carryforwards and the impact of functional currency differences in offshore jurisdictions, partially offset by increased earnings in high tax jurisdictions. The Company will continue to monitor global legislative and regulatory developments related to COVID-19 and will record the associated tax impacts as discrete events in the periods the guidance is finalized, or when the Company is able to estimate an impact. In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various final and proposed regulatory packages supplementing the TCJA provisions since 2018, which the Company does not expect to have a material impact on current or future income tax expense. The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period the guidance is finalized or becomes effective. Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credits. The Company is currently evaluating tax planning strategies that would allow utilization of the Company's foreign tax credit carryforwards. Implementation of these strategies in future periods could reduce the level of valuation allowance that is needed, thereby decreasing the Company's effective tax rate. The Company's tax returns are under audit for the years 2013 through 2015 by the United States, the Netherlands and Germany (the "Authorities"). 21 -------------------------------------------------------------------------------- Table of Contents On September 30, 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also propose to apply these adjustments to open tax years through 2019. The Company is engaged in discussions with the Authorities to evaluate the proposals and is currently evaluating all potential remedies. The Company believes that an adequate provision for income taxes has been made for all open tax years related to the examination. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised by the Authorities are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its position, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded. 14. Derivative Financial Instruments Derivatives Designated As Hedges Net Investment Hedges The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows: As of As of September 30, December 31, 2021 2020 (In € millions) Total 1,837 1,358 Cash Flow Hedges The total notional amount of the forward-starting interest rate swap designated as a cash flow hedge is as follows: As of As of September 30, December 31, 2021 2020 (In $ millions) Total — 400 Cash flows related to the settlement of forward-starting interest rate swaps are reported as financing activities. The Company settled the forward-starting interest rate swap on August 2, 2021, resulting in a payment to the counterparty of $72 million, which payment was included as part of financing activities in the unaudited interim consolidated statements of cash flows. Derivatives Not Designated As Hedges Foreign Currency Forwards and Swaps Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows: As of As of September 30, December 31, 2021 2020 (In $ millions) Total 634 546 22 -------------------------------------------------------------------------------- Table of Contents Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows: Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) Recognized in Earnings (Loss) Three Months Ended September 30, Statement of Operations 2021 2020 2021 2020 Classification (In $ millions) Designated as Cash Flow Hedges Commodity swaps 10 1 (1) (5) Cost of sales Interest rate swaps (7) 3 (1) — Interest expense Total 3 4 (2) (5) Designated as Net Investment Hedges Foreign currency denominated debt ( Note 8 ) 37 (54) — — N/A Cross-currency swaps 10 (25) — — N/A Total 47 (79) — — Not Designated as Hedges Foreign currency forwards and Foreign exchange gain (loss), swaps — — (2) (11) net; Other income (expense), net Total — — (2) (11) Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) Recognized in Earnings (Loss) Nine Months Ended September 30, Statement of Operations 2021 2020 2021 2020 Classification (In $ millions) Designated as Cash Flow Hedges Commodity swaps 33 4 (1) (5) Cost of sales Interest rate swaps 10 (50) (1) — Interest expense Total 43 (46) (2) (5) Designated as Net Investment Hedges Foreign currency denominated debt ( Note 8 ) 72 (39) — — N/A Cross-currency swaps 21 (3) — — N/A Total 93 (42) — — Not Designated as Hedges Foreign currency forwards and Foreign exchange gain (loss), swaps — — (6) 7 net; Other income (expense), net Total — — (6) 7 See Note 15 for additional information regarding the fair value of the Company's derivative instruments. Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement. 23 -------------------------------------------------------------------------------- Table of Contents Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows: As of As of September 30, December 31, 2021 2020 (In $ millions) Derivative Assets Gross amount recognized 58 26 Gross amount offset in the consolidated balance sheets — 2 Net amount presented in the consolidated balance sheets 58 24 Gross amount not offset in the consolidated balance sheets 9 11 Net amount 49 13 As of As of September 30, December 31, 2021 2020 (In $ millions) Derivative Liabilities Gross amount recognized 18 123 Gross amount offset in the consolidated balance sheets — 2 Net amount presented in the consolidated balance sheets 18 121 Gross amount not offset in the consolidated balance sheets 9 11 Net amount 9 110 15. Fair Value Measurements The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows: Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy. 24 -------------------------------------------------------------------------------- Table of Contents Fair Value Measurement Quoted Prices in Active Significant Markets for Other Identical Observable Assets Inputs (Level 1) (Level 2) Total Balance Sheet Classification (In $ millions) As of September 30, 2021 Derivatives Designated as Cash Flow Hedges Commodity swaps — 15 15 Current Other assets Commodity swaps — 24 24 Noncurrent Other assets Derivatives Designated as Net Investment Hedges Cross-currency swaps — 14 14 Current Other assets Derivatives Not Designated as Hedges Foreign currency forwards and swaps — 5 5 Current Other assets Total assets — 58 58 Derivatives Designated as Net Investment Hedges Cross-currency swaps — (2) (2) Current Other liabilities Cross-currency swaps — (9) (9) Noncurrent Other liabilities Derivatives Not Designated as Hedges Foreign currency forwards and swaps — (7) (7) Current Other liabilities Total liabilities — (18) (18) Fair Value Measurement Quoted Prices in Active Significant Markets for Other Identical Observable Assets Inputs (Level 1) (Level 2) Total Balance Sheet Classification (In $ millions) As of December 31, 2020 Derivatives Designated as Cash Flow Hedges Commodity swaps — 2 2 Current Other assets Commodity swaps — 8 8 Noncurrent Other assets Derivatives Designated as Net Investment Hedges Cross-currency swaps — 13 13 Current Other assets Derivatives Not Designated as Hedges Foreign currency forwards and swaps — 1 1 Current Other assets Total assets — 24 24 Derivatives Designated as Cash Flow Hedges Interest rate swaps — (81) (81) Current Other liabilities Commodity swaps — (1) (1) Noncurrent Other liabilities Derivatives Designated as Net Investment Hedges Cross-currency swaps — (1) (1) Current Other liabilities Cross-currency swaps — (33) (33) Noncurrent Other liabilities Derivatives Not Designated as Hedges Foreign currency forwards and swaps — (5) (5) Current Other liabilities Total liabilities — (121) (121) 25 -------------------------------------------------------------------------------- Table of Contents Carrying values and fair values of financial instruments that are not carried at fair value are as follows: Fair Value Measurement Significant Other Observable Unobservable Carrying Inputs Inputs Amount (Level 2) (Level 3) Total (In $ millions) As of September 30, 2021 Equity investments without readily determinable fair values 170 — — — Insurance contracts in nonqualified trusts 28 28 — 28 Long-term debt, including current installments of long-term debt 3,772 3,731 179 3,910 As of December 31, 2020 Equity investments without readily determinable fair values 171 — — — Insurance contracts in nonqualified trusts 30 31 — 31 Long-term debt, including current installments of long-term debt 3,671 3,644 201 3,845 In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement. As of September 30, 2021, and December 31, 2020, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt. 16. Commitments and Contingencies Commitments Guarantees The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations. The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following: •Demerger Obligations In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") ( Note 10 ). The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of September 30, 2021 are $100 million. Though the Company is significantly 26 -------------------------------------------------------------------------------- Table of Contents under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled. The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors. Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued. •Divestiture Obligations The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk ( Note 10 ). The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $116 million as of September 30, 2021. Other agreements do not provide for any monetary or time limitations. Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued. Purchase Obligations In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of September 30, 2021, the Company had unconditional purchase obligations of $3.3 billion, which extend through 2042. Contingencies The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition compliance, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy stockholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position. European Commission Investigation In May 2017, the Company learned that the European Commission had opened a competition law investigation involving certain subsidiaries of the Company with respect to certain past ethylene purchases. Based on information learned from the European Commission regarding its investigation, Celanese recorded a reserve of $89 million in 2019, which was included within the Company's Other Activities segment. In July 2020, Celanese reached a final settlement with the European Commission in respect of this matter of $92 million, which was included in Current Other liabilities as of December 31, 2020. On January 12, 2021, the Company paid $100 million to fully settle this matter. The difference between the amount reserved and the settlement payment relates to foreign exchange rates. 27 -------------------------------------------------------------------------------- Table of Contents 17. Segment Information Engineered Acetyl Other Materials Acetate Tow Chain Activities Eliminations Consolidated (In $ millions) Three Months Ended September 30, 2021 Net sales 684 128 1,489 — (35) (1) 2,266 Other (charges) gains, net ( Note 12 ) — — 1 (1) — — Operating profit (loss) 91 12 517 (84) — 536 Equity in net earnings (loss) of affiliates 39 — 1 4 — 44 Depreciation and amortization 35 10 44 4 — 93 Capital expenditures 36 10 73 4 — 123 (2) Three Months Ended September 30, 2020 Net sales 526 129 776 — (20) (1) 1,411 Other (charges) gains, net ( Note 12 ) (10) — 1 (1) — (10) Operating profit (loss) 84 30 121 (51) — 184 Equity in net earnings (loss) of affiliates 21 — 2 2 — 25 Depreciation and amortization 34 9 41 5 — 89 Capital expenditures 21 10 37 8 — 76 (2) ______________________________ (1)Includes intersegment sales primarily related to the Acetyl Chain. (2)Includes an increase in accrued capital expenditures of $21 million and $4 million for the three months ended September 30, 2021 and 2020, respectively. 28 -------------------------------------------------------------------------------- Table of Contents Engineered Acetyl Other Materials Acetate Tow Chain Activities Eliminations Consolidated (In $ millions) Nine Months Ended September 30, 2021 Net sales 2,011 385 3,954 — (88) (1) 6,262 Other (charges) gains, net ( Note 12 ) 6 — 1 (4) — 3 Operating profit (loss) 344 52 1,284 (251) — 1,429 Equity in net earnings (loss) of affiliates 96 — 5 9 — 110 Depreciation and amortization 105 29 128 12 — 274 Capital expenditures 92 31 171 15 — 309 (2) As of September 30, 2021 Goodwill and intangible assets, net 994 154 286 — — 1,434 Total assets 4,205 1,088 4,327 1,963 — 11,583 Nine Months Ended September 30, 2020 Net sales 1,509 385 2,237 — (67) (1) 4,064 Other (charges) gains, net ( Note 12 ) (35) (1) 6 (7) — (37) Operating profit (loss) 173 88 377 (177) — 461 Equity in net earnings (loss) of affiliates 100 — 3 10 — 113 Depreciation and amortization 100 26 122 13 — 261 Capital expenditures 73 26 118 25 — 242 (2) As of December 31, 2020 Goodwill and intangible assets, net 1,030 154 301 — — 1,485 Total assets 3,990 975 3,930 2,014 — 10,909 ______________________________ (1)Includes intersegment sales primarily related to the Acetyl Chain. (2)Includes an increase in accrued capital expenditures of $5 million and a decrease of $37 million for the nine months ended September 30, 2021 and 2020, respectively. 18. Revenue Recognition The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of September 30, 2021, the Company had $622 million of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $88 million of its remaining performance obligations as Net sales in 2021, $227 million in 2022, $148 million in 2023 and the balance thereafter. Contract Balances Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets ( Note 7 ). The Company does not have any material contract assets as of September 30, 2021. Disaggregated Revenue In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations. The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customers' unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment. 29 -------------------------------------------------------------------------------- Table of Contents Within the Acetate Tow business segment, the Company's primary product is acetate tow, which is managed through contracts with a few major tobacco companies and accounts for a significant amount of filters used in cigarette production worldwide. The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its emulsion polymers, redispersible powders and ethylene vinyl acetate ("EVA") polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue. Further disaggregation of Net sales by business segment and geographic destination is as follows: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 (In $ millions) Engineered Materials North America 194 147 546 420 Europe and Africa 282 222 882 665 Asia-Pacific 185 141 518 381 South America 23 16 65 43 Total 684 526 2,011 1,509 Acetate Tow North America 24 24 77 72 Europe and Africa 64 64 204 203 Asia-Pacific 39 40 99 101 South America 1 1 5 9 Total 128 129 385 385 Acetyl Chain North America 405 246 1,046 728 Europe and Africa 458 251 1,188 753 Asia-Pacific 540 243 1,530 640 South America 51 16 102 49 Total(1) 1,454 756 3,866 2,170 ______________________________ (1)Excludes intersegment sales of $35 million and $20 million for the three months ended September 30, 2021 and 2020, respectively. Excludes intersegment sales of $88 million and $67 million for the nine months ended September 30, 2021 and 2020, respectively. 30 -------------------------------------------------------------------------------- Table of Contents 19. Earnings (Loss) Per Share Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 (In $ millions, except share data) Amounts attributable to Celanese Corporation Earnings (loss) from continuing operations 519 209 1,384 544 Earnings (loss) from discontinued operations (13) (2) (18) (12) Net earnings (loss) 506 207 1,366 532 Weighted average shares - basic 110,532,051 118,045,476 112,101,651 118,543,853 Incremental shares attributable to equity awards(1) 512,507 519,344 597,646 575,350 Weighted average shares - diluted 111,044,558 118,564,820 112,699,297 119,119,203 ______________________________ (1)There were no antidilutive equity award shares excluded for the three months ended September 30, 2021 and 2020. There were 67 and 8,127 equity award shares excluded for the nine months ended September 30, 2021 and 2020, respectively, as their effect would have been antidilutive. 31 -------------------------------------------------------------------------------- Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese U.S." refers to the Company's subsidiary, Celanese U.S. Holdings LLC, a Delaware limited liability company, and not its subsidiaries. The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, 2020 filed on February 11, 2021 with the Securities and Exchange Commission ("SEC") as part of the Company's Annual Reporting on Form 10-K ("2020 Form 10-K") and the unaudited interim consolidated financial statements and notes to the unaudited interim consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Forward-Looking Statements" below and at the beginning of our 2020 Form 10-K. Forward-Looking Statements Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. Generally, words such as "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," and "will," and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and involve risks and uncertainties that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise. COVID-19 Update The COVID-19 pandemic and the various responses thereto, including government-imposed quarantines, stay-at-home restrictions, travel restrictions and other public health and safety measures, continue to evolve. Our employees' health and well-being continue to be of vital importance and we continue to monitor the pandemic in the areas where we have employees and operations. We implemented government recommended protocols and best practices related to social distancing and hygiene. We implemented careful return-to-office efforts in accordance with government regulations and recommended protocols. After declining during 2020, consumer demand for most applications has increased and rebounded to pre-COVID-19 levels within many regions of the world, which has positively impacted our results of operations. Where we temporarily reduced run rates in prior quarters, our plants are now operating at more normalized levels, and we have been able to maintain a largely consistent supply chain. We currently anticipate that the extent to which COVID-19 impacts customer demand will continue to moderate, subject to effective rollout of vaccines and the impact of resurgences and other variants of COVID-19. Like many companies, we have experienced a tightening labor market, with increased competitiveness and higher costs for the pool of talent critical for specialty manufacturing and other operations. Labor market challenges continued during the third quarter of 2021. Due to potential impacts of COVID-19 resurgences and variants, some uncertainty remains in the pandemic's future duration and scope. The extent to which resurgences or other variants of COVID-19 may adversely impact demand for our products, availability and price of raw materials and the labor supply, and therefore our business, financial condition and results of operations, will depend on numerous factors, including the effectiveness of vaccines, the extent and locations of any resurgences of the virus, health and safety measures and the continuing impact of the pandemic on supply chains (including the availability and cost of transportation and materials). In addition, on September 9, 2021, the President directed the Occupational Safety and Health Administration to promulgate rules requiring large employers to mandate employee vaccinations. The extent of the regulatory and potential cost impact of these rules, referred to as the emergency temporary standard ("ETS"), is not clear, but the ETS could impose additional costs on our operations. These factors are uncertain, rapidly changing and cannot be 32 -------------------------------------------------------------------------------- Table of Contents predicted. For further information regarding the impact COVID-19 could have on our business, financial condition and results of operations, see Part I - Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2020. For further discussion of our liquidity condition, see Liquidity and Capital Resources in this Part I - Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Risk Factors See Part I - Item 1A. Risk Factors of our 2020 Form 10-K for a description of certain risk factors that you should consider which could significantly affect our financial results. In addition, the following factors, among others, could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements: •the extent to which resurgences or other variants of COVID-19 adversely impact the economic environment, market demand and our operations, as well as the pace of any economic recovery; •changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; •the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries; •changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; •the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; •the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; •the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; •increased price competition and the introduction of competing products by other companies; •the ability to identify desirable potential acquisition targets and to complete acquisition or investment transactions, including obtaining regulatory approvals, consistent with our strategy; •market acceptance of our technology; •compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather, natural disasters, or other crises; •the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us; •changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations that may impact recorded or future tax liabilities and the impacts of potential regulatory and legislative tax developments in the United States or other jurisdictions; •changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; •potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change; •potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; •changes in currency exchange rates and interest rates; and 33 -------------------------------------------------------------------------------- Table of Contents •various other factors, both referenced and not referenced in this Quarterly Report. Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates. Overview We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals, for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures. Our large and diverse global customer base primarily consists of major companies across a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of execution, strong performance built on differentiated business models and a clear focus on growth and value creation. Known for operational excellence, reliability and execution of our business strategies, we partner with our customers around the globe to deliver best-in-class technologies and solutions. On June 30, 2021, we signed a definitive agreement to acquire the Santoprene™ thermoplastic vulcanizates ("TPV") elastomers business of Exxon Mobil Corporation. See Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information. 34 -------------------------------------------------------------------------------- Table of Contents Results of Operations Financial Highlights Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 Change 2021 2020 Change (unaudited) (In $ millions, except percentages) Statement of Operations Data Net sales 2,266 1,411 855 6,262 4,064 2,198 Gross profit 715 327 388 1,961 917 1,044 Selling, general and administrative ("SG&A") expenses (165) (106) (59) (463) (345) (118) Other (charges) gains, net — (10) 10 3 (37) 40 Operating profit (loss) 536 184 352 1,429 461 968 Equity in net earnings (loss) of affiliates 44 25 19 110 113 (3) Non-operating pension and other postretirement employee benefit (expense) income 37 28 9 113 83 30 Interest expense (21) (28) 7 (70) (83) 13 Dividend income - equity investments 35 29 6 114 98 16 Earnings (loss) from continuing operations before tax 622 241 381 1,691 680 1,011 Earnings (loss) from continuing operations 520 211 309 1,388 550 838 Earnings (loss) from discontinued operations (13) (2) (11) (18) (12) (6) Net earnings (loss) 507 209 298 1,370 538 832 Net earnings (loss) attributable to Celanese Corporation 506 207 299 1,366 532 834 Other Data Depreciation and amortization 93 89 4 274 261 13 SG&A expenses as a percentage of Net sales 7.3 % 7.5 % 7.4 % 8.5 % Operating margin(1) 23.7 % 13.0 % 22.8 % 11.3 % Other (charges) gains, net Restructuring (1) (9) 8 (5) (17) 12 Asset impairments — (2) 2 (2) (31) 29 Plant/office closures 1 1 — 10 6 4 Commercial disputes — — — — 6 (6) European Commission investigation — — — — (2) 2 Other — — — — 1 (1) Total Other (charges) gains, net — (10) 10 3 (37) 40 ______________________________ (1)Defined as Operating profit (loss) divided by Net sales. As of As of September 30, December 31, 2021 2020 (unaudited) (In $ millions) Balance Sheet Data Cash and cash equivalents 1,340 955 Short-term borrowings and current installments of long-term debt - third party and affiliates 103 496 Long-term debt, net of unamortized deferred financing costs 3,724 3,227 Total debt 3,827 3,723 35 -------------------------------------------------------------------------------- Table of Contents Factors Affecting Business Segment Net Sales The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows: Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020 Volume Price Currency Other Total (unaudited) (In percentages) Engineered Materials 11 17 2 — 30 Acetate Tow — (2) — 1 (1) Acetyl Chain 11 80 1 — 92 Total Company 10 50 1 — 61 Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020 Volume Price Currency Other Total (unaudited) (In percentages) Engineered Materials 18 10 5 — 33 Acetate Tow 1 (1) — — — Acetyl Chain 14 61 2 — 77 Total Company 14 37 3 — 54 Consolidated Results Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020 Net sales increased $855 million, or 61%, for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher pricing in most of our segments, primarily driven by our Acetyl Chain segment due to increased customer demand and supply constraints across all regions; and •higher volume in our Engineered Materials and Acetyl Chain segments, primarily due to increased demand across all regions due to recovery from the COVID-19 pandemic. Selling, general and administrative expenses increased $59 million, or 56%, for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •an increase in functional spending and incentive compensation costs of $42 million in Other Activities. Operating profit increased $352 million, or 191%, for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher Net sales across most of our segments; partially offset by: •higher raw material and energy costs across all of our segments; and •higher spending across most of our segments, primarily as a result of plant operating and administrative expenses. 36 -------------------------------------------------------------------------------- Table of Contents Equity in net earnings (loss) of affiliates increased $19 million for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •an increase in equity investment in earnings of $19 million from our Ibn Sina strategic affiliate primarily due to global economic recovery and higher oil prices. Our effective income tax rate for the three months ended September 30, 2021 was 16% compared to 12% for the same period in 2020. The higher effective income tax rate for the three months ended September 30, 2021 compared to the same period in 2020 was primarily due to increased earnings in high tax jurisdictions. See Note 13 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information. Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020 Net sales increased $2.2 billion, or 54%, for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher pricing in most of our segments, primarily driven by our Acetyl Chain segment due to increased customer demand and supply constraints across all regions; •higher volume in our Engineered Materials and Acetyl Chain segments, primarily due to increased demand across most regions due to recovery from the COVID-19 pandemic; and •a favorable currency impact resulting from a stronger Euro relative to the U.S. dollar. Selling, general and administrative expenses increased $118 million, or 34%, for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •an increase in functional spending and incentive compensation costs of $79 million in Other Activities. Operating profit increased $968 million, or 210%, for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher Net sales across most of our segments; and •lower plant turnaround costs in our Engineered Materials segment; partially offset by: •higher raw material and energy costs across all of our segments; and •higher spending across all of our segments, primarily as a result of increased plant operating and maintenance expenses. Non-operating pension and other postretirement employee benefit income increased $30 million, or 36%, for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •lower interest cost. Our effective income tax rate for the nine months ended September 30, 2021 was 18% compared to 19% for the same period in 2020. The lower effective income tax rate for the nine months ended September 30, 2021 compared to the same period in 2020 was primarily due to non-recurring adjustments in the prior periods to uncertain tax positions due to available attribute carryforwards and the impact of functional currency differences in offshore jurisdictions, partially offset by increased earnings in high tax jurisdictions. See Note 13 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information. 37 -------------------------------------------------------------------------------- Table of Contents Business Segments Engineered Materials Three Months Ended September 30, % Nine Months Ended September 30, % 2021 2020 Change Change 2021 2020 Change Change (unaudited) (In $ millions, except percentages) Net sales 684 526 158 30.0 % 2,011 1,509 502 33.3 % Net Sales Variance Volume 11 % 18 % Price 17 % 10 % Currency 2 % 5 % Other — % — % Other (charges) gains, net — (10) 10 100.0 % 6 (35) 41 117.1 % Operating profit (loss) 91 84 7 8.3 % 344 173 171 98.8 % Operating margin 13.3 % 16.0 % 17.1 % 11.5 % Equity in net earnings (loss) of affiliates 39 21 18 85.7 % 96 100 (4) (4.0) % Depreciation and amortization 35 34 1 2.9 % 105 100 5 5.0 % Our Engineered Materials segment includes our engineered materials business, our food ingredients business and certain strategic affiliates. Our engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with our strategic affiliates, our engineered materials business is a leading participant in the global specialty polymers industry. Our food ingredients business is a leading global supplier of acesulfame potassium for the food and beverage industry and is a leading producer of preservatives, such as potassium sorbate and sorbic acid. The pricing of products within the Engineered Materials segment is primarily based on the value of the material we produce and is generally independent of changes in the cost of raw materials, but may be impacted during periods of inflation and increased costs. Therefore, in general, margins may expand or contract in response to changes in raw material costs. Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020 Net sales increased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher pricing for most of our products, primarily due to higher raw material costs and product mix; and •higher volume for most of our products driven by increased demand across all regions due to recovery from the COVID-19 pandemic. Operating profit increased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher Net sales; and •a favorable impact of $10 million to Other (charges) gains, net. During the three months ended September 30, 2020, we recorded $8 million in employee termination benefits, primarily related to business optimization projects, which did not recur in the current year. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information; partially offset by: •higher raw material costs across all products and increased distribution costs as a result of higher logistical costs and global shipping constraints; 38 -------------------------------------------------------------------------------- Table of Contents •higher spending of $47 million, primarily as a result of plant operating and administrative expenses; and •higher energy costs of $27 million, primarily for steam. Equity in net earnings (loss) of affiliates increased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •an increase in equity investment in earnings of $19 million from our Ibn Sina strategic affiliate primarily due to global economic recovery and higher oil prices. Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020 Net sales increased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher volume for most of our products driven by increased demand across all regions due to recovery from the COVID-19 pandemic; •higher pricing for most of our products, primarily due to higher raw material costs and product mix; and •a favorable currency impact resulting from a stronger Euro relative to the U.S. dollar. Operating profit increased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher Net sales; •a favorable impact of $41 million to Other (charges) gains, net. During the nine months ended September 30, 2020, we recorded a $26 million long-lived asset impairment loss related to certain fixed assets used in compounding operations at our facilities in Kaiserslautern, Germany; Wehr, Germany and Ferrara Marconi, Italy and $9 million in employee termination benefits, primarily related to business optimization projects. During the nine months ended September 30, 2021, we recorded a $9 million gain on the termination of our Ferrara Marconi, Italy office lease. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information; and •lower plant turnaround costs of $23 million, primarily related to our Bishop plant in 2020; partially offset by: •higher raw material costs across all products and increased distribution costs as a result of higher logistical costs and global shipping constraints; •higher spending of $62 million, primarily as a result of plant operating and administrative expenses; and •higher energy costs of $48 million, primarily for steam. 39 -------------------------------------------------------------------------------- Table of Contents Acetate Tow Nine Months Ended Three Months Ended September 30, % September 30, % 2021 2020 Change Change 2021 2020 Change Change (unaudited) (In $ millions, except percentages) Net sales 128 129 (1) (0.8) % 385 385 — — % Net Sales Variance Volume — % 1 % Price (2) % (1) % Currency — % — % Other 1 % — % Other (charges) gains, net — — — — % — (1) 1 100.0 % Operating profit (loss) 12 30 (18) (60.0) % 52 88 (36) (40.9) % Operating margin 9.4 % 23.3 % 13.5 % 22.9 % Dividend income - equity investments 34 28 6 21.4 % 112 97 15 15.5 % Depreciation and amortization 10 9 1 11.1 % 29 26 3 11.5 % Our Acetate Tow segment serves consumer-driven applications. We are a leading global producer and supplier of acetate tow and acetate flake, primarily used in filter products applications. The pricing of products within the Acetate Tow segment is sensitive to demand and is primarily based on the value of the product we produce. Many sales in this business are conducted under contracts with pricing for one or more years. As a result, margins may expand or contract in response to changes in market conditions over these similar periods, and we may be unable to adjust pricing also due to other factors, such as the intense level of competition in the industry. Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020 Net sales were flat for the three months ended September 30, 2021 compared to the same period in 2020. Operating profit decreased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher energy costs of $9 million, primarily related to natural gas pricing; and •higher raw material costs of $8 million, primarily for acetic acid. Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020 Net sales were flat for the nine months ended September 30, 2021 compared to the same period in 2020. Operating profit decreased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher energy and spending costs of $23 million, primarily related to higher natural gas pricing and plant operating costs; and •higher raw material costs of $9 million, primarily for acetic acid. Dividend income from equity investments increased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher earnings from our Nantong, Zhuhai and Kunming Cellulose Fibers joint ventures related to higher volumes due to stronger financial performance and a favorable currency impact. 40 -------------------------------------------------------------------------------- Table of Contents Acetyl Chain Three Months Ended September 30, % Nine Months Ended September 30, % 2021 2020 Change Change 2021 2020 Change Change (unaudited) (In $ millions, except percentages) Net sales 1,489 776 713 91.9 % 3,954 2,237 1,717 76.8 % Net Sales Variance Volume 11 % 14 % Price 80 % 61 % Currency 1 % 2 % Other — % — % Other (charges) gains, net 1 1 — — % 1 6 (5) (83.3) % Operating profit (loss) 517 121 396 327.3 % 1,284 377 907 240.6 % Operating margin 34.7 % 15.6 % 32.5 % 16.9 % Depreciation and amortization 44 41 3 7.3 % 128 122 6 4.9 % Our Acetyl Chain segment includes the integrated chain of our intermediate chemistry, emulsion polymers, ethylene vinyl acetate ("EVA") polymers and redispersible powders ("RDP") businesses. Our intermediate chemistry business produces and supplies acetyl products, including acetic acid, vinyl acetate monomer ("VAM"), acetic anhydride and acetate esters. These products are generally used as starting materials for colorants, paints, adhesives, coatings and pharmaceuticals. It also produces organic solvents and intermediates for pharmaceutical, agricultural and chemical products. Our emulsion polymers business is a leading global producer of vinyl acetate-based emulsions and develops products and application technologies to improve performance, create value and drive innovation in applications such as paints and coatings, adhesives, construction, glass fiber, textiles and paper. Our EVA polymers business is a leading North American manufacturer of a full range of specialty EVA resins and compounds, as well as select grades of low-density polyethylene. Our EVA polymers products are used in many applications, including flexible packaging films, lamination film products, hot melt adhesives, automotive parts and carpeting. Our RDP business is a leading manufacturer of redispersible polymer powders, sold under the Elotex® brand. The business produces polymer emulsions which are converted into powdered thermoplastic resin materials. RDP products are used in a variety of applications in the mortar industry, including decorative mortar, exterior insulation and finish systems, gypsum-based materials, plaster and render, self-leveling floor systems, skim coat and tile adhesives. The pricing of products within the Acetyl Chain is influenced by industry utilization rates and changes in the cost of raw materials. Therefore, in general, there is a directional correlation between these factors and our Net sales for most Acetyl Chain products. This impact to pricing typically lags changes in raw material costs over months or quarters. Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020 Net sales increased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher pricing for all of our products, primarily due to increased customer demand and supply constraints across all regions; and •higher volume for most of our products driven by increased demand across most regions due to recovery from the COVID-19 pandemic. Operating profit increased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher Net sales; partially offset by: •higher raw material costs, primarily for ethylene, methanol and carbon monoxide, as well as higher sourcing and distribution costs due to stronger demand and tighter market conditions; 41 -------------------------------------------------------------------------------- Table of Contents •higher spending of $21 million, primarily as a result of increased plant operating and maintenance expenses; and •higher energy costs of $16 million, primarily driven by price increases for, and increased consumption of, natural gas due to increased volumes. Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020 Net sales increased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher pricing for all of our products, primarily due to increased customer demand and supply constraints across all regions; •higher volume for all of our products driven by increased demand across most regions due to recovery from the COVID-19 pandemic; and •a favorable currency impact resulting from a stronger Euro relative to the U.S. dollar. Operating profit increased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher Net sales; partially offset by: •higher raw material costs, primarily for ethylene, methanol and carbon monoxide, as well as higher sourcing and distribution costs due to stronger demand and tighter market conditions; •higher spending of $68 million, primarily as a result of increased plant operating and maintenance expenses, fixed overhead, freeze-related repairs and restart costs resulting from Winter Storm Uri; and •higher energy costs of $46 million, primarily due to supply disruptions caused by Winter Storm Uri, price increases for, and increased consumption of, natural gas due to increased volumes. 42 -------------------------------------------------------------------------------- Table of Contents Other Activities Three Months Ended September 30, % Nine Months Ended September 30, % 2021 2020 Change Change 2021 2020 Change Change (unaudited) (In $ millions, except percentages) Other (charges) gains, net (1) (1) — — % (4) (7) 3 42.9 % Operating profit (loss) (84) (51) (33) (64.7) % (251) (177) (74) (41.8) % Equity in net earnings (loss) of affiliates 4 2 2 100.0 % 9 10 (1) (10.0) % Non-operating pension and other postretirement employee benefit (expense) income 37 28 9 32.1 % 113 83 30 36.1 % Dividend income - equity investments 1 1 — — % 2 1 1 100.0 % Depreciation and amortization 4 5 (1) (20.0) % 12 13 (1) (7.7) % Other Activities primarily consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expense associated with financing activities and results of our captive insurance companies. Other Activities also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for our defined benefit pension plans and other postretirement plans not allocated to our business segments. Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020 Operating loss increased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher functional spending and incentive compensation costs of $42 million; partially offset by: •a gain on the sale of our Spondon site of $14 million. Non-operating pension and other postretirement employee benefit income increased for the three months ended September 30, 2021 compared to the same period in 2020, primarily due to: •lower interest cost. Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020 Operating loss increased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •higher functional spending and incentive compensation costs of $79 million. Non-operating pension and other postretirement employee benefit income increased for the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to: •lower interest cost. 43 -------------------------------------------------------------------------------- Table of Contents Liquidity and Capital Resources Our primary sources of liquidity are cash generated from operations, available cash and cash equivalents, dividends from our portfolio of strategic investments and available borrowings under our senior unsecured revolving credit facility. As of September 30, 2021, we have $1.3 billion available for borrowing under our senior unsecured revolving credit facility, if required, in meeting our working capital needs and other contractual obligations. In addition, we held cash and cash equivalents of $1.3 billion as of September 30, 2021. We are actively managing our business to maintain cash flow, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future. On June 30, 2021, we signed a definitive agreement to acquire the Santoprene™ thermoplastic vulcanizates ("TPV") elastomers business of Exxon Mobil Corporation for a purchase price of $1.15 billion in an all-cash transaction. See Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information. While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels. Total cash outflows for capital expenditures are expected to be in the range of $500 million to $550 million in 2021, primarily due to additional investments in growth opportunities and productivity improvements in our Engineered Materials and Acetyl Chain segments. On a stand-alone basis, Celanese and its immediate 100% owned subsidiary, Celanese U.S., have no independent external operations of their own. Accordingly, they generally depend on the cash flow of their subsidiaries and their ability to pay dividends and make other distributions to Celanese and Celanese U.S. in order to meet their obligations, including their obligations under senior credit facilities and senior notes, and to pay dividends on our Common Stock. We are subject to capital controls and exchange restrictions imposed by the local governments in certain jurisdictions where we operate, such as China, India and Indonesia. Capital controls impose limitations on our ability to exchange currencies, repatriate earnings or capital, lend via intercompany loans or create cross-border cash pooling arrangements. Our largest exposure to a country with capital controls is in China. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, the Chinese government imposes certain currency exchange controls on cash transfers out of China, puts certain limitations on duration, purpose and amount of intercompany loans, and restricts cross-border cash pooling. While it is possible that future tightening of these restrictions or application of new similar restrictions could impact us, these limitations do not currently restrict our operations. We remain in compliance with the financial covenants under our senior unsecured revolving credit facility and expect to remain in compliance based on our current expectation of future results of operations. If our actual future results of operations differ materially from these expectations, or if we otherwise experience increased indebtedness or substantially lower EBITDA, we may be required to seek an amendment or waiver of such covenants which may increase our borrowing costs under those debt instruments. Cash Flows Cash and cash equivalents increased $385 million to $1.3 billion as of September 30, 2021 compared to December 31, 2020. As of September 30, 2021, $777 million of the $1.3 billion of cash and cash equivalents was held by our foreign subsidiaries. Upon adoption of the TCJA, we previously incurred a charge associated with the deemed repatriation of previously unremitted foreign earnings, including foreign held cash. These funds are largely accessible without additional material tax consequences, if needed in the U.S., to fund operations. 44 -------------------------------------------------------------------------------- Table of Contents •Net Cash Provided by (Used in) Operating Activities Net cash provided by operating activities increased $104 million to $1.2 billion for the nine months ended September 30, 2021 compared to the same period in 2020. Net cash provided by operating activities for the nine months ended September 30, 2021 increased, primarily due to: •an increase in Net earnings; partially offset by: •unfavorable trade working capital of $567 million, primarily due to an increase in trade receivables and inventory, partially offset by an increase in trade payables. Trade receivables increased primarily as a result of the increase in Net sales and inventory increased primarily as a result of higher costs for raw materials during the nine months ended September 30, 2021. Payables increased as a result of higher costs for raw materials and the timing of settlement of trade payables; •an increase in VAT taxes receivable, primarily due to timing of refunds and COVID-19 relief measures during the nine months ended September 30, 2020, which did not recur in the current year; and •a payment for the European Commission settlement of $100 million, see Note 16 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements for further information. •Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities increased $554 million to $167 million for the nine months ended September 30, 2021 compared to net cash used in investing activities of $387 million for the same period in 2020, primarily due to: •an increase in proceeds from the sale of marketable securities of $500 million; and •a net cash outflow of $85 million primarily related to the acquisition of Nouryon's redispersible polymer powders business offered under the Elotex® brand in April 2020, which did not recur in the current year. •Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities increased $405 million to $943 million for the nine months ended September 30, 2021 compared to $538 million for the same period in 2020, primarily due to: •an increase in share repurchases of our Common Stock of $531 million during the nine months ended September 30, 2021; and •a settlement of a forward-starting interest rate swap on August 2, 2021 resulting in a payment to the counterparty of $72 million; partially offset by: •an increase in net proceeds from long-term debt of $236 million, primarily due to the issuance of $400 million in principal amount of 1.400% senior unsecured notes due August 5, 2026 (the "1.400% Notes") and the issuance of €500 million in principal amount of 0.625% senior unsecured notes due September 10, 2028 (the "0.625% Notes"), partially offset by the maturity and repayment in full of the 5.875% senior unsecured notes (the "5.875% Notes") and tender offer for 1.125% senior unsecured notes due September 26, 2023 (the "1.125% Notes") during the nine months ended September 30, 2021, as discussed below. Debt and Other Obligations On August 5, 2021, Celanese U.S. completed an offering of $400 million in principal amount of 1.400% Notes in a public offering registered under the Securities Act. Net proceeds from the sale of the 1.400% Notes were used to repay $396 million of outstanding borrowings under the senior unsecured revolving credit facility and for general corporate purposes. On September 10, 2021, Celanese U.S. completed an offering of €500 million in principal amount of 0.625% Notes due September 10, 2028 in a public offering registered under the Securities Act. 45 -------------------------------------------------------------------------------- Table of Contents On September 13, 2021, Celanese U.S. completed a cash tender offer for €300 million in principal amount of 1.125% Notes at a purchase price of €1,027.35 per €1,000 of principal amount plus accrued interest, for a total principal and premium payment of $363 million plus accrued interest of $4 million. A portion of the proceeds from the issuance of the 0.625% Notes were used to fund the tender offer for €300 million of the 1.125% Notes. As a result of the tender offer, the carrying value of the 1.125% Notes were reduced by $353 million. There have been no material changes to our debt or other obligations described in our 2020 Form 10-K other than those disclosed above and in Note 8 - Debt in the accompanying unaudited interim consolidated financial statements. Accounts Receivable Purchasing Facility On June 18, 2021, we entered into an amendment to the amended and restated receivables purchase agreement under our U.S. accounts receivable purchasing facility among certain of our subsidiaries, our wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). We de-recognized $812 million and $595 million of accounts receivable under this agreement for the nine months ended September 30, 2021 and twelve months ended December 31, 2020, respectively, and collected $812 million and $476 million of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $116 million were pledged by the SPE as collateral to the Purchasers as of September 30, 2021. Factoring and Discounting Agreements We have factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. We de-recognized $134 million and $233 million of accounts receivable under these factoring agreements for the nine months ended September 30, 2021 and twelve months December 31, 2020, respectively, and collected $133 million and $237 million of accounts receivable sold under these factoring agreements during the same periods. In March 2021, we entered into an agreement in Singapore with a financial institution to discount, on a non-recourse basis, documentary credits or other documents recorded as accounts receivable. We de-recognized $57 million of accounts receivable under this agreement for the nine months ended September 30, 2021. Guarantor Financial Information The Senior Notes were issued by Celanese U.S. ("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (collectively the "Obligor Group"). See Note 8 - Debt in the accompanying unaudited interim consolidated financial statements for further information. The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Parent Guarantor and Subsidiary Guarantors represent substantially all of our U.S. assets and business operations. The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report. The Parent Guarantor and the Subsidiary Guarantors have guaranteed the Senior Notes on a full and unconditional, joint and several, senior unsecured basis. The guarantees are subject to certain customary release provisions, including that a Subsidiary Guarantor will be released from its respective guarantee in specified circumstances, including (i) the sale or transfer of all of its assets or capital stock; (ii) its merger or consolidation with, or transfer of all or substantially all of its assets to, another person; or (iii) its ceasing to be a majority-owned subsidiary of the Issuer in connection with any sale of its capital stock or other transaction. Additionally, a Subsidiary Guarantor will be released from its guarantee of the Senior Notes at such time that it ceases to guarantee the Issuer's obligations under the Credit Agreement (subject to the satisfaction of customary document delivery requirements). The obligations of the Subsidiary Guarantors under their guarantees are limited as necessary to prevent such guarantees from constituting a fraudulent conveyance or fraudulent transfer under applicable law. The Parent Guarantor and the Issuer are holding companies that conduct substantially all of their operations through their subsidiaries, which own substantially all of our consolidated assets. The Parent Guarantor has no material assets other than the stock of its immediate 100% owned subsidiary, the Issuer. The principal source of cash to pay the Parent Guarantor's and the Issuer's obligations, including obligations under the Senior Notes and the guarantee of the Issuer's obligations under the Credit Agreement, is the cash that our subsidiaries generate from their operations. Each of the Subsidiary Guarantors and our non-guarantor subsidiaries is a distinct legal entity and, under certain circumstances, applicable country or state laws, regulatory limitations and terms of other debt instruments may limit our subsidiaries' ability to distribute cash to the Issuer and the Parent Guarantor. While the Credit Agreement and the Indentures generally limit the ability of our subsidiaries to restrict payment of dividends or other distributions to us, these limitations are subject to certain qualifications and exceptions, which may have the effect of significantly limiting the applicability of those restrictions. 46 -------------------------------------------------------------------------------- Table of Contents For cash management purposes, we transfer cash among the Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. While the non-guarantor subsidiaries do not guarantee the Issuer's obligations under our outstanding debt, the transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Senior Notes, Credit Agreement, other outstanding debt, Common Stock dividends and Common Stock repurchases. The summarized financial information of the Obligor Group is presented below on a combined basis after the elimination of: (i) intercompany transactions among such entities and (ii) equity in earnings from and investments in the non-guarantor subsidiaries. Transactions with, and amounts due to or from, non-guarantor subsidiaries and affiliates are separately disclosed. Nine Months Ended September 30, 2021 (In $ millions) (unaudited) Net sales to third parties 1,263 Net sales to non-guarantor subsidiaries 671 Total net sales 1,934 Gross profit 293 Earnings (loss) from continuing operations 77 Net earnings (loss) 58 Net earnings (loss) attributable to the Obligor Group 58 As of As of September 30, December 31, 2021 2020 (In $ millions) (unaudited) Receivables from non-guarantor subsidiaries 370 318 Other current assets 1,360 1,597 Total current assets 1,730 1,915 Goodwill 405 399 Other noncurrent assets 3,788 3,519 Total noncurrent assets 4,193 3,918 Current liabilities due to non-guarantor subsidiaries 2,329 1,206 Current liabilities due to affiliates 77 58 Other current liabilities 650 958 Total current liabilities 3,056 2,222 Noncurrent liabilities due to non-guarantor subsidiaries 1,588 1,593 Other noncurrent liabilities 4,168 3,648 Total noncurrent liabilities 5,756 5,241 Share Capital On July 14, 2021, our Board of Directors approved a $1.0 billion increase in our Common Stock repurchase authorization. We also declared a quarterly cash dividend of $0.68 per share on our Common Stock on October 20, 2021, amounting to $74 million. There have been no material changes to our share capital described in our 2020 Form 10-K other than those disclosed above and in Note 11 - Stockholders' Equity in the accompanying unaudited interim consolidated financial statements. Contractual Obligations Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our 2020 Form 10-K. 47 -------------------------------------------------------------------------------- Table of Contents Tax Return Audits Our tax returns are under audit for the years 2013 through 2015 by the United States, the Netherlands and Germany (the "Authorities"). On September 30, 2021, we received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also propose to apply these adjustments to open tax years through 2019. We are engaged in discussions with the Authorities to evaluate the proposals and are currently evaluating all potential remedies. We believe that an adequate provision for income taxes has been made for all open tax years related to the examination. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised by the Authorities are resolved in a manner inconsistent with our expectations or we are unsuccessful in defending our position, we could be required to adjust our provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded. Off-Balance Sheet Arrangements We have not entered into any material off-balance sheet arrangements. Critical Accounting Policies and Estimates Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results. We describe our significant accounting policies in Note 2 - Summary of Accounting Policies, of the Notes to the Consolidated Financial Statements included in our 2020 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our 2020 Form 10-K. Recent Accounting Pronouncements See Note 2 - Recent Accounting Pronouncements in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report for information regarding recent accounting pronouncements. Item 3. Quantitative and Qualitative Disclosures about Market Risk Market risk for the Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our 2020 Form 10-K. See also Note 14 - Derivative Financial Instruments in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on the Company's financial position and results of operations. 48 -------------------------------------------------------------------------------- Table of Contents Item 4. Controls and Procedures Disclosure Controls and Procedures Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, as of September 30, 2021, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective. Changes in Internal Control Over Financial Reporting During the period covered by this report, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 49 -------------------------------------------------------------------------------- Table of Contents PART II — OTHER INFORMATION Item 1. Legal Proceedings The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of its business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust and competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy stockholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where it is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss may not represent the ultimate loss to the Company from legal proceedings. See Note 10 - Environmental and Note 16 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements for a discussion of material environmental matters and material commitments and contingencies related to legal and regulatory proceedings. There have been no significant developments in the "Legal Proceedings" described in our 2020 Form 10-K other than those disclosed in Note 10 - Environmental and Note 16 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements. See Part I - Item 1A. Risk Factors of our 2020 Form 10-K for certain risk factors relating to these legal proceedings. Item 1A. Risk Factors There have been no material changes to the risk factors under Part I, Item 1A of our 2020 Form 10-K. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Repurchases of our Common Stock during the three months ended September 30, 2021 are as follows: Approximate Dollar Value of Shares Total Number of Remaining that may Total Number Average Shares Purchased as be of Shares Price Paid Part of Publicly Purchased Under the Period Purchased(1) per Share Announced Program Program(2) (unaudited) July 1 - 31, 2021 96,594 $ 155.96 96,594 $ 1,548,000,000 August 1 - 31, 2021 922,143 $ 157.36 922,143 $ 1,403,000,000 September 1 - 30, 2021 919,442 $ 152.09 919,442 $ 1,263,000,000 Total 1,938,179 1,938,179 ______________________________ (1)May include shares withheld from employees to cover their withholding requirements for personal income taxes related to the vesting of restricted stock. (2)As of September 30, 2021, our Board of Directors had authorized the repurchase of $6.9 billion of our Common Stock since February 2008. See Note 11 - Stockholders' Equity in the accompanying unaudited interim consolidated financial statements for further information. Item 3. Defaults Upon Senior Securities None. Item 4. Mine Safety Disclosures None. Item 5. Other Information None. 50 -------------------------------------------------------------------------------- Table of Contents Item 6. Exhibits(1) Exhibit Number Description 3.1 Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q filed with the SEC on October 18, 2016). 3.1(a) Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Celanese Corporation dated as of April 21, 2016 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on April 22, 2016). 3.1(b) Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Celanese Corporation dated as of September 17, 2018 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on September 17, 2018). 3.1(c) Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Celanese Corporation dated April 18, 2019 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on April 23, 2019). 3.2 Sixth Amended and Restated By-laws, amended effective July 15, 2019 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on July 18, 2019). 4.1 Tenth Supplemental Indenture, dated as of August 5, 2021, among Celanese US Holdings LLC, Celanese Corporation, the subsidiary guarantors party thereto and Wells Fargo Bank, National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed with the SEC on August 5, 2021). 4.2 Eleventh Supplemental Indenture, dated as of September 10, 2021, among Celanese US Holdings LLC, Celanese Corporation, the subsidiary guarantors party thereto and Wells Fargo Bank, National Association, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed with the SEC on September 10, 2021). 22.1* List of Guarantor Subsidiaries. 31.1* Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1* Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2* Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS* Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH* Inline XBRL Taxonomy Extension Schema Document. 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104 The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 has been formatted in Inline XBRL. * Filed herewith. (1)The Company and its subsidiaries have in the past issued, and may in the future issue from time to time, long-term debt. The Company may not file with the applicable report copies of the instruments defining the rights of holders of long-term debt to the extent that the aggregate principal amount of the debt instruments of any one series of such debt instruments for which the instruments have not been filed has not exceeded or will not exceed 10% of the assets of the Company at any pertinent time. The Company hereby agrees to furnish a copy of any such instrument(s) to the SEC upon request. 51 -------------------------------------------------------------------------------- Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CELANESE CORPORATION By: /s/ LORI J. RYERKERK Lori J. Ryerkerk Chairman of the Board of Directors, Chief Executive Officer and President Date: October 22, 2021 By: /s/ SCOTT A. RICHARDSON Scott A. Richardson Executive Vice President and Chief Financial Officer Date: October 22, 2021 52 EX-22.1 2 ex2219302110-q.htm EX-22.1 Exhibit 22.1 List of Guarantor Subsidiaries (As of September 30, 2021) Celanese US Holdings LLC (the "Issuer"), a 100% owned subsidiary of Celanese Corporation (the "Parent"), has 4.625% Senior Notes due 2022, 1.125% Senior Notes due 2023, 3.50% Senior Notes due 2024, 1.250% Senior Notes due 2025, 1.400% Senior Notes due 2026, 2.125% Senior Notes due 2027 and 0.625% Senior Notes due 2028 (collectively, the "Senior Notes"). The Senior Notes are jointly and severally guaranteed on a full and unconditional basis by the Parent and the 100% owned subsidiaries of the Parent listed below. Name of Company Jurisdiction Parent Guarantor Celanese Corporation Delaware Subsidiary Guarantors Celanese Acetate LLC Delaware Celanese Americas LLC Delaware Celanese Chemicals, Inc. Delaware Celanese Global Relocation LLC Delaware Celanese International Corporation Delaware Celanese Ltd. Texas Celanese Sales U.S. Ltd. Texas Celtran, Inc. Delaware CNA Holdings LLC Delaware KEP Americas Engineering Plastics, LLC Delaware Ticona Fortron Inc. Delaware Ticona LLC Delaware Ticona Polymers, Inc. Delaware EX-31.1 3 ex3119302110-q.htm EX-31.1 Exhibit 31.1 CERTIFICATION PURSUANT TO 17 CFR 240.13a-14 PROMULGATED UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lori J. Ryerkerk, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. /s/ LORI J. RYERKERK Lori J. Ryerkerk Chairman of the Board of Directors, Chief Executive Officer and President October 22, 2021 EX-31.2 4 ex3129302110-q.htm EX-31.2 Exhibit 31.2 CERTIFICATION PURSUANT TO 17 CFR 240.13a-14 PROMULGATED UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Scott A. Richardson, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. /s/ SCOTT A. RICHARDSON Scott A. Richardson Executive Vice President and Chief Financial Officer October 22, 2021 EX-32.1 5 ex3219302110-q.htm EX-32.1 Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lori J. Ryerkerk, Chairman of the Board of Directors, Chief Executive Officer and President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: 1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ LORI J. RYERKERK Lori J. Ryerkerk Chairman of the Board of Directors, Chief Executive Officer and President October 22, 2021 EX-32.2 6 ex3229302110-q.htm EX-32.2 Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Scott A. Richardson, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: 1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ SCOTT A. RICHARDSON Scott A. Richardson Executive Vice President and Chief Financial Officer October 22, 2021